Skip to content

Oxurion

Active
Public limited companyfounded 200620 yrs activeGaston Geenslaan 1, 3001 Leuven, BelgiumKBO/BCE: BE 0881.620.924
Summary

Oxurion has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show negative equity (-€10.5m) and a net result of -€199,230. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 4610 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
44 / 100
Weak
Negative equity caps the score. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability49▲+49
Solvency0=
Growth38=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.24 against 0.31 in 2023; short-term debt: 387% and cash: 10.5% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Activities of head offices; management consultancy activities (NACE 70)
about 69% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
-302.3%
Return on assets
-5.7%
Age of the figures
21 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 20 years 0 30 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024
Equity per financial year
18192021222324
2018 to 2024 · latest year -€10.5m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
31 d early
2024
34 d early
2023
43 d early
2022
60 d early
2021
53 d early
2020
43 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 44 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 30 May 2006, Oxurion was incorporated by BIGGAR LIMITED, with a starting capital of EUR 62,000.12 The capital was increased 57 times between 2007 and 2026, most recently to EUR 87 million.345 Since 2018 the company has been called Oxurion.6 Of the 8 current board members, MeRoNo has served longest, since 2021.7 Revenue went from EUR 4.4 million in 2018 to EUR 2,952 in 2024 and headcount from 62.2 to 8.4 full-time equivalents.8

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 14-06-2006
  3. 3Belgian State Gazette, 29-05-2007
  4. 4Belgian State Gazette, 30-06-2026
  5. 5Belgian State Gazette, 27-08-2026
  6. 6Belgian State Gazette, 06-09-2018
  7. 7Belgian State Gazette, 26-09-2023
  8. 8National Bank, annual accounts 2018 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, full schema, statutory accounts

Turnover
€2,952▼ 98.9%
2023 · €262,637
EBIT margin
11547.3%▲ 16201.4pp
2023 · -4654.1%
Net result
-€199,230▲ 98.5%
2023 · -€13.4m
Working capital
-€10.2m▲ 15.9%
2023 · -€12.1m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Turnover€2.0m▼ 36.1%€1.1m▼ 46.1%€595,419▼ 43.5%€262,637▼ 55.9%€2,952▼ 98.9%
Operating result-€27.6m▲ 46.0%-€25.4m▲ 7.9%-€22.8m▲ 10.5%-€12.2m▲ 46.3%€340,903
Net result-€26.9mbelow the sector's middle half▲ 46.4%-€36.7mbelow the sector's middle half▼ 36.4%-€24.5mbelow the sector's middle half▲ 33.3%-€13.4mbelow the sector's middle half▲ 45.4%-€199,230below the sector's middle half▲ 98.5%
EBIT margin-1412.1%▲ 258.8pp-2412.0%▼ 999.9pp-3824.7%▼ 1412.7pp-4654.1%▼ 829.4pp11547.3%▲ 16201.4pp
Equity€34.0mabove the sector's middle half▼ 44.2%-€1.4mbelow the sector's middle half-€6.4mbelow the sector's middle half▼ 362%-€12.2mbelow the sector's middle half▼ 90.4%-€10.5mbelow the sector's middle half▲ 13.9%
Total assets€41.1mabove the sector's middle half▼ 40.8%€16.8mabove the sector's middle half▼ 59.2%€8.4mabove the sector's middle half▼ 49.6%€5.8mwithin the sector's middle half▼ 31.2%€3.5mwithin the sector's middle half▼ 40.1%
Debt€7.1m▼ 16.2%€18.1m▲ 156%€14.9m▼ 18.1%€18.0m▲ 21.3%€14.0m▼ 22.4%
Working capital€22.4m▼ 57.5%€5.4m▼ 75.9%-€2.6m-€12.1m▼ 369%-€10.2m▲ 15.9%
Solvency82.7%above the sector's middle half▼ 5.1pp-8.3%below the sector's middle half▼ 91.0pp-76.0%below the sector's middle half▼ 67.7pp-210.3%below the sector's middle half▼ 134.3pp-302.3%below the sector's middle half▼ 91.9pp
Staff (FTE)60.2above the sector's middle half▼ 12.8%43.1above the sector's middle half▼ 28.4%26.7above the sector's middle half▼ 38.1%14.4above the sector's middle half▼ 46.1%8.4within the sector's middle half▼ 41.7%
above within below the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€40.0m-€30.0m-€20.0m-€10.0m€0Operating result 2020: -€27.6m-€27.6mNet result 2020: -€26.9m-€26.9mOperating result 2021: -€25.4m-€25.4mNet result 2021: -€36.7m-€36.7mOperating result 2022: -€22.8m-€22.8mNet result 2022: -€24.5m-€24.5mOperating result 2023: -€12.2m-€12.2mNet result 2023: -€13.4m-€13.4mOperating result 2024: €340,903€340,903Net result 2024: -€199,230-€199,23020202021202220232024-€30m-€20m-€10m€0Operating result 2022: -€22.8m-€23mNet result 2022: -€24.5m-€24mOperating result 2023: -€12.2m-€12mNet result 2023: -€13.4m-€13mOperating result 2024: €340,903€341,000Net result 2024: -€199,230-€199,000202220232024
The operating result returns to profit in 2024: €340,903 after a loss of €12.2m in 2023, the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €3.5m
Fixed assets €187,763 ▼ 38.1%
Current assets €3.3m ▼ 40.2%
Key figures and ratios
2024 value · change against 2023
EBITDA
€360,568▲
2023 · -€1.1m
Cash flow
-€179,566▲
2023 · -€2.3m
Current ratio
0.24▼
2023 · 0.31
Debt to equity
-1.33▲
2023 · -1.48
ROA
-5.7%▲
2023 · -229.8%
Interest coverage
1.44▲
2023 · -0.58
Debt ≤ 1 year
€13.5m▼
2023 · €17.6m
Income taxes
€1,176▲
2023 · -€564,182
Staff costs
€1.2m▼
2023 · €2.8m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,798 companies that looked in July 2024 the way this one looks now, 1.9% went bankrupt within 24 months and 90% are still going.

  • Micro
  • 20 years or older
  • negative equity
  • a small loss
1.9% went bankrupt
6.0% stopped otherwise
90% still going

A further 2.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,798 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 79 lines
Balance sheet Code20232024
Assets
Total assets20/58€5.8m€3.5m▼
Fixed assets21/28€303,155€187,763▼
Tangible fixed assets22/27€55,645€23,628▼
Plant, machinery and equipment23€38,521€19,673▼
Furniture and vehicles24€8,943€911▼
Other tangible fixed assets26€8,181€3,044▼
Financial fixed assets28€247,511€164,134▼
Affiliated companies280/1€207,433€124,057▼
Participating interests280-€5,000
Amounts receivable281€207,433€119,057▼
Other financial fixed assets284/8€40,078€40,078=
Amounts receivable and cash guarantees285/8€40,078€40,078=
Current assets29/58€5.5m€3.3m▼
Amounts receivable after more than one year29€3.3m€2.0m▼
Other amounts receivable291€3.3m€2.0m▼
Amounts receivable within one year40/41€530,988€933,983▲
Trade receivables40€401,498€289,755▼
Other amounts receivable41€129,489€644,229▲
Current investments50/53€49,705-
Other investments51/53€49,705-
Cash at bank and in hand54/58€1.6m€367,265▼
Deferred charges and accrued income490/1€50,970€23,753▼
Equity and liabilities
Total equity and liabilities10/49€5.8m€3.5m▼
Equity10/15-€12.2m-€10.5m▲
Contributions10/11€83.7m€85.6m▲
Capital10€83.4m€85.3m▲
Issued capital100€83.4m€85.3m▲
Outside capital11€250,300€250,300=
Share premium1100/10€250,300€250,300=
Reserves13€5.5m€5.5m=
Non-distributable reserves130/1€5.5m€5.5m=
Reserves not available under the articles1311€5.5m€5.5m=
Profit (loss) carried forward14-€101.4m-€101.6m▼
Amounts payable17/49€18.0m€14.0m▼
Amounts payable within one year42/48€17.6m€13.5m▼
Current portion of amounts payable after more than one year42€1.9m€301,284▼
Financial debts43€7.4m€8.6m▲
Other loans439€7.4m€8.6m▲
Trade debts44€2.4m€1.8m▼
Suppliers440/4€2.4m€1.8m▼
Taxes, remuneration and social security45€677,492€281,941▼
Taxes450/3€34,553€59,202▲
Remuneration and social security454/9€642,939€222,739▼
Other amounts payable47/48€5.2m€2.5m▼
Accrued charges and deferred income492/3€421,620€531,155▲
Income statement Code20232024
Operating income70/76A€13.2m€4.2m▼
Turnover70€262,637€2,952▼
Own construction capitalised72€11.1m-
Other operating income74€1.4m€3.2m▲
Non-recurring operating income76A€532,233€959,451▲
Operating charges60/66A€25.4m€3.8m▼
Goods for resale, raw materials and consumables60€2.2m€278,470▼
Purchases600/8€2.2m€278,470▼
Change in stocks: decrease (increase)609€8,435-
Services and other goods61€9.2m€2.3m▼
Remuneration, social security and pensions62€2.8m€1.2m▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11.1m€19,664▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€3,052-
Other operating charges640/8€114,480€2,400▼
Non-recurring operating charges66A€75€12,351▲
Operating profit (loss)9901-€12.2m€340,903▲
Financial income75/76B€421,263€38,580▼
Recurring financial income75€421,263€38,580▼
Income from current assets751€9,422€8,228▼
Other financial income752/9€411,840€30,353▼
Financial charges65/66B€2.1m€577,538▼
Recurring financial charges65€2.1m€577,538▼
Debt charges650€1.9m€250,417▼
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651-€4,172-
Other financial charges652/9€182,489€327,121▲
Profit (loss) for the period before taxes9903-€13.9m-€198,054▲
Income taxes67/77-€564,182€1,176▲
Taxes670/3€3,185€1,176▼
Tax adjustments and reversals of tax provisions77€567,366-
Profit (loss) for the period9904-€13.4m-€199,230▲
Profit (loss) for the period to be appropriated9905-€13.4m-€199,230▲
Appropriation of the result
Profit (loss) to be appropriated9906-€101.4m-€101.6m▼
Profit (loss) brought forward from the previous period14P-€88.1m-€101.4m▼
Social balance
Average headcount (FTE)908714.48.4▼

The notes to these accounts (80 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Operating income70/76A-€26.5m€19.9m€13.2m€4.2m▼ 68.5%
Turnover70€2.0m€1.1m€595,419€262,637€2,952▼ 98.9%
Own construction capitalised72-€23.7m€17.9m€11.1m--
Other operating income74-€1.4m€1.4m€1.4m€3.2m▲ 136%
Non-recurring operating income76A-€329,482€1,379€532,233€959,451▲ 80.3%
Operating charges60/66A-€51.9m€42.7m€25.4m€3.8m▼ 85.0%
Goods for resale, raw materials and consumables60-€4.5m€3.3m€2.2m€278,470▼ 87.4%
Purchases600/8-€5.1m€3.3m€2.2m€278,470▼ 87.4%
Change in stocks: decrease (increase)609--€603,808€22,022€8,435--
Services and other goods61-€15.6m€15.1m€9.2m€2.3m▼ 74.9%
Remuneration, social security and pensions62-€7.4m€4.9m€2.8m€1.2m▼ 56.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17.8m€23.7m€17.9m€11.1m€19,664▼ 99.8%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€282,553€34,939-€3,052--
Other operating charges640/8-€431,276€415,309€114,480€2,400▼ 97.9%
Non-recurring operating charges66A-€99€1.0m€75€12,351▲ 16,368%
Operating profit (loss)9901-€27.6m-€25.4m-€22.8m-€12.2m€340,903▲ 103%
Financial income75/76B-€138,174€232,561€421,263€38,580▼ 90.8%
Recurring financial income75€481,487€138,174€232,561€421,263€38,580▼ 90.8%
Income from current assets751-€53,099€34,415€9,422€8,228▼ 12.7%
Other financial income752/9-€85,076€198,146€411,840€30,353▼ 92.6%
Financial charges65/66B-€12.2m€2.5m€2.1m€577,538▼ 72.7%
Recurring financial charges65€371,384€875,063€1.7m€2.1m€577,538▼ 72.7%
Debt charges650€11,517€711,457€1.3m€1.9m€250,417▼ 87.1%
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651-€1,233€3,926-€4,172--
Other financial charges652/9-€162,373€400,577€182,489€327,121▲ 79.3%
Non-recurring financial charges66B-€11.3m€771,877---
Profit (loss) for the period before taxes9903-€27.5m-€37.5m-€25.1m-€13.9m-€198,054▲ 98.6%
Income taxes67/77-€594,047-€798,908-€599,235-€564,182€1,176▲ 100%
Taxes670/3-€671€3,403€3,185€1,176▼ 63.1%
Tax adjustments and reversals of tax provisions77-€799,579€602,638€567,366--
Profit (loss) for the period9904-€26.9m-€36.7m-€24.5m-€13.4m-€199,230▲ 98.5%
Profit (loss) for the period to be appropriated9905-€26.9m-€36.7m-€24.5m-€13.4m-€199,230▲ 98.5%
Line20202021202220232024Change
Assets
Total assets20/58€41.1m€16.8m€8.4m€5.8m€3.5m▼ 40.1%
Fixed assets21/28€12.4m€2.1m€338,384€303,155€187,763▼ 38.1%
Intangible fixed assets21€1.0m€1.0m----
Tangible fixed assets22/27€195,636€118,206€97,927€55,645€23,628▼ 57.5%
Plant, machinery and equipment23-€97,896€70,940€38,521€19,673▼ 48.9%
Furniture and vehicles24-€12,927€16,595€8,943€911▼ 89.8%
Other tangible fixed assets26-€7,383€10,392€8,181€3,044▼ 62.8%
Financial fixed assets28€11.2m€965,685€240,457€247,511€164,134▼ 33.7%
Affiliated companies280/1-€870,877€200,380€207,433€124,057▼ 40.2%
Participating interests280-€770,877--€5,000-
Amounts receivable281-€100,000€200,380€207,433€119,057▼ 42.6%
Other financial fixed assets284/8-€94,808€40,078€40,078€40,078=
Amounts receivable and cash guarantees285/8-€94,808€40,078€40,078€40,078=
Current assets29/58€28.6m€14.7m€8.1m€5.5m€3.3m▼ 40.2%
Amounts receivable after more than one year29-€3.6m€3.5m€3.3m€2.0m▼ 40.0%
Other amounts receivable291-€3.6m€3.5m€3.3m€2.0m▼ 40.0%
Stocks and contracts in progress3€161,259€60,323€5,382---
Stocks30/36-€60,323€5,382---
Goods purchased for resale34-€60,323€5,382---
Amounts receivable within one year40/41€1.0m€1.1m€926,544€530,988€933,983▲ 75.9%
Trade receivables40-€236,446€734,904€401,498€289,755▼ 27.8%
Other amounts receivable41-€905,870€191,639€129,489€644,229▲ 398%
Current investments50/53€277,581€242,291€94,927€49,705--
Other investments51/53-€242,291€94,927€49,705--
Cash at bank and in hand54/58€23.7m€9.4m€3.3m€1.6m€367,265▼ 77.0%
Deferred charges and accrued income490/1-€149,475€300,494€50,970€23,753▼ 53.4%
Equity and liabilities
Total equity and liabilities10/49€41.1m€16.8m€8.4m€5.8m€3.5m▼ 40.1%
Equity10/15€34.0m-€1.4m-€6.4m-€12.2m-€10.5m▲ 13.9%
Contributions10/11€55.3m€56.7m€76.1m€83.7m€85.6m▲ 2.3%
Capital10-€56.4m€75.9m€83.4m€85.3m▲ 2.3%
Issued capital100-€56.4m€75.9m€83.4m€85.3m▲ 2.3%
Outside capital11-€233,519€250,300€250,300€250,300=
Share premium1100/10-€233,519€250,300€250,300€250,300=
Reserves13€5.5m€5.5m€5.5m€5.5m€5.5m=
Non-distributable reserves130/1-€5.5m€5.5m€5.5m€5.5m=
Reserves not available under the articles1311-€5.5m€5.5m€5.5m€5.5m=
Profit (loss) carried forward14-€26.9m-€63.6m-€88.1m-€101.4m-€101.6m▼ 0.2%
Amounts payable17/49€7.1m€18.1m€14.9m€18.0m€14.0m▼ 22.4%
Amounts payable after more than one year17-€8.4m€3.6m---
Financial debts170/4-€8.4m€3.6m---
Unsubordinated bonds171-€8.4m€3.6m---
Amounts payable within one year42/48€6.3m€9.3m€10.7m€17.6m€13.5m▼ 23.5%
Current portion of amounts payable after more than one year42-€1.6m€3.0m€1.9m€301,284▼ 84.4%
Financial debts43-€1.7m€500,000€7.4m€8.6m▲ 16.2%
Other loans439-€1.7m€500,000€7.4m€8.6m▲ 16.2%
Trade debts44€4.0m€3.4m€2.4m€2.4m€1.8m▼ 24.4%
Suppliers440/4-€3.4m€2.4m€2.4m€1.8m▼ 24.4%
Taxes, remuneration and social security45-€1.4m€522,755€677,492€281,941▼ 58.4%
Taxes450/3-€1,926€14,040€34,553€59,202▲ 71.3%
Remuneration and social security454/9-€1.4m€508,715€642,939€222,739▼ 65.4%
Other amounts payable47/48-€1.3m€4.2m€5.2m€2.5m▼ 52.5%
Accrued charges and deferred income492/3-€444,025€599,984€421,620€531,155▲ 26.0%
Line20202021202220232024Change
Profit (loss) for the period9904-€26.9m-€36.7m-€24.5m-€13.4m-€199,230▲ 98.5%
+ Depreciation and write-downs630€17.8m€23.7m€17.9m€11.1m€19,664▼ 99.8%
Operating cash flow (approximation)-€9.1m-€13.0m-€6.5m-€2.3m-€179,566▲ 92.1%
Investment in fixed assets (approximation)--€13.4m-€16.2m-€11.1m€95,729▲ 101%
Change in cash--€14.3m-€6.1m-€1.7m-€1.2m▲ 28.4%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-08
State Gazette act Capital & shares · Statutes amendment
Financial instrument · Capital increase · Share issue6 facts ▸
  • Financial instrument, 3, conversion request
  • Financial instrument, conversion, EUR
  • Capital increase, €75.000
  • Share issue, gewone aandelen, 29685310
  • Financial instrument, subscription request, 150000.0
  • Financial instrument, 6, issue
30-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €75.000
  • Share issue, gewone aandelen, 22358269
  • Capital, €87.131.161,32
  • Statutes amendment
30-06
NBB filing Annual accounts filed
fiscal year 2025 · consolidated
30-03
State Gazette act Capital & shares · Statutes amendment
Bond issue · Capital increase · Share issue4 facts ▸
  • Bond issue, 6, 150.000,00 EUR
  • Capital increase, €100.000
  • Share issue, gewone aandelen, 18.592.918
  • Capital, €87.056.161,32
17-02
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €50.000
  • Share issue, gewone aandelen, 7500360
  • Capital, €86.956.161,32
  • Statutes amendment
26-01
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Share issue, 100.000.00
  • Share issue, 100.000.00
2025
04-11
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital4 facts ▸
  • Capital increase, €100.000
  • Capital, €86.806.161,32
  • Capital increase, €100.000
  • Capital, €86.906.161,32
08-08
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Capital13 facts ▸
  • Share issue, 4, 100.000,00 EUR
  • Capital increase, €125.000
  • Share issue, gewone aandelen, 5580809
  • Capital, €85.981.161,32
  • Capital increase, €175.000
  • Share issue, gewone aandelen, 7813133
  • Capital, €86.156.161,32
  • Capital increase, €250.000
  • Share issue, gewone aandelen, 11161618
  • Capital, €86.406.161,32
  • Capital increase, €300.000
  • Share issue, gewone aandelen, 13393942
  • +1 further facts in this act
10-07
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Capital3 facts ▸
  • Share issue, 06-06-2025
  • Capital increase, €100.000
  • Capital, €85.856.161,32
27-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
27-06
NBB filing Annual accounts filed
fiscal year 2024 · consolidated
11-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital4 facts ▸
  • Capital increase, €100.000
  • Capital, €85.656.161,32
  • Capital increase, €100.000
  • Capital, €85.756.161,32
Show earlier events
18-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Share issue3 facts ▸
  • Capital increase, €150.000
  • Capital, €85.556.161,32
  • Share issue, 250.000,00
06-03
State Gazette act Appointment: Nelly Souleymane (onafhankelijke niet uitvoerende bestuurder)
Power of attorney4 facts ▸
  • Board meeting, 14/02/2025
  • Director appointment, Nelly Souleymane (onafhankelijke niet uitvoerende bestuurder)
  • Power of attorney, Samuel Darcheville
  • Power of attorney, Sophie Kinnaer
27-02
State Gazette act Resignations: Nathalie Laarakker (director) and Anat Loewenstein (director)
3 facts ▸
  • Board meeting, 24/01/2025
  • Director resignation, Nathalie Laarakker (director)
  • Director resignation, Anat Loewenstein (director)
30-01
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital4 facts ▸
  • Capital increase, €150.000
  • Capital, €85.306.161,32
  • Capital increase, €100.000
  • Capital, €85.406.161,32
2024
19-12
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Capital3 facts ▸
  • Share issue, 18 november 2024
  • Capital increase, €150.000
  • Capital, €85.156.161,32
13-11
State Gazette act Capital & shares
Capital increase · Capital · Share issue5 facts ▸
  • Capital increase, €150.000
  • Capital, €85.006.161,32
  • Share issue, gewone aandelen, 452841
  • Bond issue, Converteerbare Obligaties, 6
  • Subscription, 11/10/2024
27-09
State Gazette act Capital & shares · Statutes amendment
Capital · Capital increase5 facts ▸
  • Board meeting, 25/07/2024
  • Capital, €84.756.161,32
  • Capital increase, €100.000
  • Capital, €84.856.161,32
  • Statutes amendment
25-09
State Gazette act Miscellaneous
Share issue2 facts ▸
  • Share issue, 150.000.00 EUR
  • Share issue, 150.000.00 EUR
23-08
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €100.000
  • Share issue, gewone aandelen, 1.086.956.521
  • Capital, €84.756.161,32
30-07
State Gazette act Miscellaneous
Statutes amendment · Power of attorney4 facts ▸
  • General meeting, 24/07/2024
  • Statutes amendment
  • Power of attorney, DARCHEVILLE Samuel
  • Power of attorney, directors of e1
18-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
18-06
NBB filing Annual accounts filed
fiscal year 2023 · consolidated
05-06
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Share issue5 facts ▸
  • Capital increase, €100.000
  • Capital, €84.456.161,32
  • Capital increase, €200.000
  • Capital, €84.656.161,32
  • Share issue, 300.000,00
23-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital8 facts ▸
  • Capital increase, €150.000
  • Share issue, gewone aandelen, 1.630.434.782
  • Capital, €84.206.161,32
  • Capital increase, €150.000
  • Share issue, gewone aandelen, 1.630.434.782
  • Capital, €84.356.161,32
  • Share issue, 18, EUR
  • Power of attorney, bestuurder van de Vennootschap
25-03
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital8 facts ▸
  • Capital increase, €150.000
  • Share issue, gewone aandelen, 543.478.260
  • Capital, €83.906.161,32
  • Capital increase, €150.000
  • Share issue, gewone aandelen, 815.217.391
  • Capital, €84.056.161,32
  • Bond issue, 300.000,00
  • Power of attorney, bestuurder
27-02
State Gazette act Resignations: Thomas Graney, MeRoNo BV and 3 others
Appointments: Charles Paris de Bollardière, James Hartmann and 3 others · Permanent representative: Pascal Ghoson · Power-of-attorney revocation17 facts ▸
  • Board meeting, 28/12/2023
  • Director resignation, Thomas Graney (director)
  • Director resignation, MeRoNo BV (director)
  • Director resignation, Thomas Clay (director)
  • Director appointment, Charles Paris de Bollardière (onafhankelijke niet uitvoerende bestuurder)
  • Director appointment, James Hartmann (onafhankelijke niet uitvoerende bestuurder)
  • Director appointment, MARS SARL (managing director)
  • Permanent representative, Pascal Ghoson
  • Director appointment, MARS SARL (day-to-day manager)
  • Director appointment, Charles Paris de Bollardière (chair)
  • Director resignation, Thomas Graney (ceo)
  • Director resignation, Kathleen Paisley (clo)
  • +5 further facts in this act
14-02
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Capital8 facts ▸
  • Share issue, 20 Converteerbare Obligaties uitgegeven voor EUR 500.000,00
  • Capital increase, €150.000
  • Capital, €83.556.161,32
  • Capital increase, €100.000
  • Capital, €83.656.161,32
  • Capital increase, €100.000
  • Capital, €83.756.161,32
  • Share issue, 14 Converteerbare Obligaties uitgegeven voor EUR 350.000,00
2023
04-12
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Share issue10 facts ▸
  • Capital increase, €50.000
  • Capital, €83.006.161,32
  • Capital increase, €100.000
  • Capital, €83.106.161,32
  • Share issue, 40, Zevende Tranche
  • Power of attorney, Aan iedere bestuurder van de Vennootschap en aan de comparant
  • Capital increase, €100.000
  • Capital, €83.206.161,32
  • Capital increase, €200.000
  • Capital, €83.406.161,32
06-11
State Gazette act Capital & shares · Statutes amendment
Share issue · Power of attorney · Capital increase18 facts ▸
  • Board meeting, 03/10/2023
  • Share issue, 32, opschortende voorwaarde
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
  • Capital increase, €100.000
  • Capital, €82.856.161,32
  • Share issue, 48, Deel 1 van de Zesde Tranche
  • Share issue, 32, in natura (commissie)
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
  • Capital increase, €100.000
  • Capital, €82.956.161,32
  • Share issue, 12, Deel 2 van de Zesde Tranche
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
  • +6 further facts in this act
26-09
State Gazette act Resignations: David Guyer, Adrienne Graves and 2 others
Appointments: Nathalie Laarakker, Anat Loewenstein and 3 others · Permanent representatives: Emmanuèle Attout and Patrik De Haes · Power of attorney17 facts ▸
  • Board meeting, 15/03/2023
  • Director resignation, David Guyer (director)
  • Director resignation, Adrienne Graves (director)
  • Director appointment, Nathalie Laarakker (onafhankelijke, niet uitvoerende bestuurder)
  • Director appointment, Anat Loewenstein (onafhankelijke, niet uitvoerende bestuurder)
  • General meeting, 02/05/2023
  • Director resignation, Baron Philippe Vlerick (director)
  • Director resignation, INVESTEA SRL (director)
  • Permanent representative, Emmanuèle Attout
  • Director appointment, Nathalie Laarakker (onafhankelijk niet uitvoerend bestuurder)
  • Director appointment, Anat Loewenstein (onafhankelijk niet uitvoerend bestuurder)
  • Director appointment, MeRoNo BV (non-executive director and chair)
  • +5 further facts in this act
26-09
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Share issue10 facts ▸
  • Capital increase, €200.000
  • Capital, €82.206.161,32
  • Capital increase, €250.000
  • Capital, €82.456.161,32
  • Capital increase, €150.000
  • Capital, €82.606.161,32
  • Share issue, 1.000.000,00
  • Power of attorney, Aan iedere bestuurder van de Vennootschap en aan de comparant
  • Capital increase, €150.000
  • Capital, €82.756.161,32
01-09
NBB filing Annual accounts filed
fiscal year 2022 · consolidated
28-08
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Share issue14 facts ▸
  • Capital increase, €150.000
  • Capital, €81.006.161,32
  • Capital increase, €300.000
  • Capital, €81.306.161,32
  • Capital increase, €200.000
  • Capital, €81.506.161,32
  • Share issue, 1.000.000,00
  • Power of attorney, bestuurder/comparant
  • Capital increase, €150.000
  • Capital, €81.656.161,32
  • Capital increase, €150.000
  • Capital, €81.806.161,32
  • +2 further facts in this act
19-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital4 facts ▸
  • Capital increase, €150.000
  • Capital, €80.706.161,32
  • Capital increase, €150.000
  • Capital, €80.856.161,32
01-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
25-05
State Gazette act Capital & shares · Statutes amendment · Miscellaneous
Capital increase · Share issue · Capital10 facts ▸
  • Capital increase, €200.000
  • Share issue, gewone aandelen, 44669446
  • Capital, €79.156.161,32
  • Capital increase, €100.000
  • Share issue, gewone aandelen, 23801967
  • Capital, €79.256.161,32
  • Bond issue, 2.000.000,00
  • Power of attorney, directors/comparant
  • Board meeting, 14/03/2023
  • Waiver of preemptive rights, Investeerder
09-05
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Capital7 facts ▸
  • Share issue, EUR 2.000.000,00
  • Capital increase, €150.000
  • Capital, €78.606.161,32
  • Capital increase, €250.000
  • Capital, €78.856.161,32
  • Capital increase, €100.000
  • Capital, €78.956.161,32
21-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital9 facts ▸
  • Capital increase, €200.000
  • Share issue, gewone aandelen, 19.013.817
  • Capital, €77.906.161,32
  • Capital increase, €300.000
  • Share issue, gewone aandelen, 28.942.629
  • Capital, €78.206.161,32
  • Capital increase, €250.000
  • Share issue, gewone aandelen, 26.728.439
  • Capital, €78.456.161,32
17-03
State Gazette act Miscellaneous
Share issue · Capital increase · Power of attorney6 facts ▸
  • Board meeting, 14/03/2023
  • Share issue, opschortende voorwaarde en in de mate van de inschrijving, 832
  • Share issue, 112, Converteerbare Obligaties (Eerste Tranche Deel A)
  • Capital increase
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
  • Preemption waiver
23-02
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Share issue13 facts ▸
  • Capital increase, €500.000
  • Capital, €76.356.161,32
  • Share issue, 540, 1.350.000,00
  • Capital increase, €150.000
  • Capital, €76.506.161,32
  • Capital increase, €200.000
  • Capital, €76.706.161,32
  • Capital increase, €400.000
  • Capital, €77.106.161,32
  • Capital increase, €400.000
  • Capital, €77.506.161,32
  • Capital increase, €200.000
  • +1 further facts in this act
2022
16-12
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital23 facts ▸
  • Capital increase, €140.000
  • Share issue, gewone aandelen, 14.705.882
  • Capital, €73.121.161,32
  • Capital increase, €430.000
  • Share issue, gewone aandelen, 45.168.067
  • Capital, €73.551.161,32
  • Capital increase, €350.000
  • Share issue, gewone aandelen, 36.764.705
  • Capital, €73.901.161,32
  • Capital increase, €605.000
  • Share issue, gewone aandelen, 63.550.419
  • Capital, €74.506.161,32
  • +11 further facts in this act
21-11
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Bond issue18 facts ▸
  • Capital increase, €265.000
  • Share issue, gewone aandelen, 3785714
  • Bond issue, Soort B Converteerbare Obligaties, 520
  • Capital increase, €145.000
  • Share issue, gewone aandelen, 2071428
  • Capital, €71.748.661,32
  • Capital increase, €300.000
  • Share issue, gewone aandelen, 5000000
  • Capital, €72.048.661,32
  • Capital increase, €307.500
  • Share issue, gewone aandelen, 6150000
  • Capital, €72.356.161,32
  • +6 further facts in this act
21-10
State Gazette act Capital & shares
Capital increase · Share issue · Capital7 facts ▸
  • Capital increase, €100.000
  • Share issue, gewone aandelen, 909090
  • Capital increase, €332.500
  • Share issue, gewone aandelen, 4750000
  • Capital, €71.338.661,32
  • Statutes amendment
  • Power of attorney, Midico
21-09
State Gazette act Capital & shares
Capital increase · Capital2 facts ▸
  • Capital increase, €200.000
  • Capital, €70.906.161,32
12-09
State Gazette act Miscellaneous
Share issue · Capital increase · Power of attorney6 facts ▸
  • Board meeting, 05-09-2022
  • Share issue, maximaal 2.400 Soort B Converteerbare Obligaties (max. totaalwaarde EUR 6.000.000,00, nominale waarde EUR 2.500,00) en 280 W&C Fee Converteerbare Obligaties (to…
  • Capital increase
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
  • Preemption waiver, Opheffing van het voorkeurrecht
  • Tranche issue, Definitieve uitgifte en effectieve inschrijving op een eerste tranche van converteerbare obligaties
12-09
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney4 facts ▸
  • Capital increase, €200.000
  • Capital, €70.706.161,32
  • Statutes amendment
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeline Mia
22-08
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €500.000
  • Share issue, gewone aandelen, 1785714
  • Capital, €70.506.161,32
17-08
State Gazette act Miscellaneous
Share issue1 fact ▸
  • Share issue, 400, EUR 1.000.000,00
15-07
State Gazette act Capital & shares
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €550.000
  • Share issue, gewone aandelen, 1447368
  • Capital, €70.006.161,32
  • Power of attorney, Midico
15-06
State Gazette act Appointment: PwC Bedrijfsrevisoren BV (statutory auditor)
Permanent representatives: Didier Delanoye and Patrik De Haes · Reappointments: Thomas Clay, MeRoNo BV and 3 others9 facts ▸
  • General meeting, 03/05/2022
  • Auditor appointment, PwC Bedrijfsrevisoren BV (statutory auditor)
  • Permanent representative, Didier Delanoye
  • Director reappointment, Thomas Clay (onafhankelijk niet uitvoerend bestuurder)
  • Director reappointment, MeRoNo BV (non-executive director)
  • Permanent representative, Patrik De Haes
  • Director reappointment, Dr. David Guyer (onafhankelijk niet uitvoerend bestuurder)
  • Director reappointment, Adrienne Graves (onafhankelijk niet uitvoerend bestuurder)
  • Director reappointment, Thomas Graney (executive director)
15-06
State Gazette act Resignations & appointments
General meeting1 fact ▸
  • General meeting, 03/05/2022
14-06
State Gazette act Capital & shares
Capital increase · Capital · Share issue3 facts ▸
  • Capital increase, €450.000
  • Capital, €69.456.161,32
  • Share issue, gewone aandelen, 1216216
08-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
30-05
State Gazette act Miscellaneous
Statutes amendment · Power of attorney5 facts ▸
  • General meeting, 24/05/2022
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, DILLEN Michaël
23-05
State Gazette act Capital & shares
Capital increase · Capital2 facts ▸
  • Capital increase, €500.000
  • Capital, €69.006.161,32
05-05
State Gazette act Miscellaneous
Share issue · Power of attorney2 facts ▸
  • Share issue, 600, EUR 1.500.000,00
  • Power of attorney, directors and comparant
22-04
State Gazette act Capital & shares
Capital increase · Capital2 facts ▸
  • Capital increase, €575.000
  • Capital, €68.506.161,32
28-03
State Gazette act Capital & shares
Capital increase · Capital · Share issue3 facts ▸
  • Capital increase, €600.000
  • Capital, €67.931.161,32
  • Share issue, gewone aandelen, 500000
17-03
State Gazette act Capital & shares
Capital increase · Share issue · Bank account6 facts ▸
  • Board meeting, 07/03/2022
  • Capital increase, €10.405.500
  • Share issue, aandelen zonder vermelding van nominale waarde, 7226039
  • Bank account, 07/03/2022
  • Capital, €67.331.161,32
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
15-02
State Gazette act Capital & shares
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €483.219,36
  • Share issue, gewone aandelen, 335569
  • Capital, €56.925.661,32
04-02
State Gazette act Reappointments: Thomas Clay (director) and Adrienne Graves (independent director)
Appointment: MeRoNo BV (bestuurder) · Permanent representative: Patrik De Haes · Mandate compensation11 facts ▸
  • General meeting, 04/05/2021
  • General meeting, 09/11/2021
  • Director reappointment, Thomas Clay (director)
  • Mandate compensation, Thomas Clay
  • Director reappointment, Adrienne Graves (independent director)
  • Mandate compensation, Adrienne Graves
  • Power of attorney, Michaël Dillen
  • Director appointment, MeRoNo BV ((niet uitvoerend) bestuurder)
  • Mandate compensation, MeRoNo BV
  • Permanent representative, Patrik De Haes
  • Power of attorney, Michaël Dillen
13-01
State Gazette act Miscellaneous
Share issue · Capital increase · Power of attorney5 facts ▸
  • Board meeting, 30/12/2021
  • Share issue, Inschrijvingsrechtenplan 2021/3, inschrijvingsrechten
  • Capital increase
  • Power of attorney, Benoemings- en Remuneratiecomité evenals elk van de niet-uitvoerende bestuurders met twee (2) samen handelend
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
07-01
State Gazette act Capital & shares
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €293.022,72
  • Share issue, gewone aandelen, 203488
  • Capital, €56.442.441,96
2021
27-12
State Gazette act Miscellaneous
Bond issue · Capital increase · Power of attorney4 facts ▸
  • Board meeting, 20/12/2021
  • Bond issue, 100, converteerbare obligaties
  • Capital increase
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
02-12
State Gazette act Capital & shares
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €378.946,08
  • Share issue, gewone aandelen, 263157
  • Capital, €56.149.419,24
  • Bond conversion, EUR, 500.000,00
09-11
State Gazette act Miscellaneous
Share issue · Power of attorney2 facts ▸
  • Share issue, 600, EUR 1.500.000,00
  • Power of attorney, bestuurder van de Vennootschap en de comparant
25-10
State Gazette act Resignation: ViBio BV (director)
Permanent representatives: Patrik De Haes and Michaël Dillen · Appointments: Tom Graney (ceo) and MeRoNo BV (non-executive director) · Power of attorney13 facts ▸
  • Board meeting, 15/05/2021
  • General meeting, 13/08/2021
  • Director resignation, ViBio BV (director)
  • Director resignation, ViBio BV (executive director)
  • Permanent representative, Patrik De Haes
  • Director appointment, Tom Graney (ceo)
  • Director appointment, MeRoNo BV (non-executive director)
  • Permanent representative, Patrik De Haes
  • Director appointment, MeRoNo BV (chair)
  • Power of attorney, Michaël Dillen
  • Permanent representative, Michaël Dillen
  • Director appointment, Tom Graney (director)
  • +1 further facts in this act
25-10
State Gazette act Capital & shares · Resignations & appointments
Share issue · Capital increase · Power of attorney4 facts ▸
  • Board meeting, 22/09/2021
  • Share issue, inschrijvingsrechten, 550.000
  • Capital increase
  • Power of attorney, DILLEN Michaël Raphaël Flora Marcel Madeleine Mia
25-10
State Gazette act Capital & shares
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €225.000
  • Share issue, gewone aandelen, 156250
  • Capital, €55.770.473,16
21-10
State Gazette act Capital & shares
Capital increase · Share issue · Capital3 facts ▸
  • Capital increase, €219.512,16
  • Share issue, gewone aandelen, 152439
  • Capital, €55.545.473,16
19-10
State Gazette act Miscellaneous
Share issue · Power of attorney3 facts ▸
  • Share issue, 400, Converteerbare Obligaties
  • Share issue, 210, Converteerbare Obligaties (Commitment Fee CB's)
  • Power of attorney, Peter VAN MELKEBEKE
19-08
State Gazette act Miscellaneous
Share issue · Power of attorney · Waiver of preemptive rights8 facts ▸
  • Board meeting, 22 juli 2021
  • Share issue, maximaal tweeduizend (2.000) converteerbare obligaties tegen inbreng in geld
  • Share issue, tweehonderdentien (210) converteerbare obligaties tegen inbreng in natura van de reserveringsvergoeding
  • Power of attorney, Dillen Michaël Raphaël Flora Marcel Madeleine Mia
  • Power of attorney, iedere bestuurder
  • Waiver of preemptive rights, opheffing wettelijk voorkeurrecht ten voordele van Investeerder
  • Authorized capital usage, 5.525.000,00, EUR
  • Max shares conversion, 38.291.950
18-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
18-06
NBB filing Annual accounts filed
fiscal year 2020 · consolidated
27-04
State Gazette act Miscellaneous
Share issue · Capital increase · Waiver of preemptive rights8 facts ▸
  • Board meeting, 14 april 2021
  • Share issue, inschrijvingsrechten, 1.085.000
  • Capital increase
  • Waiver of preemptive rights, opheffing van het wettelijk voorkeurrecht van de bestaande aandeelhouders
  • Legal deviation, afwijking van artikel 7:91 WVV inzake uitoefening vóór 3 jaar en spreiding variabele remuneratie voor CEO
  • Authorization, machtigingen aan Benoemings- en Remuneratiecomité en Niet-Uitvoerende Bestuurders voor uitvoering plan, regeling modaliteiten, vaststelling uitoefening en kapit…
  • Issue premium booking, uitgiftepremie op onbeschikbare rekening geboekt, waarborg voor derden, beschikking alleen door algemene vergadering
  • Prior share issue, 150.000 inschrijvingsrechten uitgegeven op 23 december 2020 voor Niet-Uitvoerende Bestuurders
18-01
State Gazette act Miscellaneous
Subscription rights issue · Capital increase · Power of attorney9 facts ▸
  • Board meeting, 23 december 2020
  • Subscription rights issue, inschrijvingsrechten, 150.000
  • Capital increase
  • Power of attorney, Benoemings- en Remuneratiecomité en CEO
  • Preemption waiver, implementatie Inschrijvingsrechtenplan 2020, Niet-Uitvoerende Bestuurders
  • Statutory deviation, 7:91 WVV
  • Subscription rights allocation, 7.500, jaarlijks in december
  • Subscription rights lapse, openbaar overnamebod, FSMA kennisgeving
  • Subscription rights nullification, automatisch nietig en zonder enige waarde, einde laatste uitoefenperiode
2020
28-08
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Capital6 facts ▸
  • General meeting, 06/08/2020
  • General meeting, 24/08/2020
  • Capital decrease, €50.198.374,38
  • Capital decrease, €5.532.596,62
  • Capital, €55.325.961
  • Statutes amendment
14-01
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Capital · Power of attorney6 facts ▸
  • General meeting, 13/12/2019
  • General meeting, 30/12/2019
  • Capital decrease, €111.056.932
  • Capital, €111.056.932
  • Statutes amendment
  • Power of attorney, Oxurion
2019
31-12
Financial Weakest financial yearnet -€50.2m
Net result drops to -€50.2m, the lowest in the series; recovery starts the following year.
08-08
State Gazette act Resignation: Paul Howes (director)
Appointments: Adrienne Graves (director) and BDO Bedrijfsrevisoren (statutory auditor) · Reappointments: Philippe Vlerick (director) and Investea BVBA (director) · Permanent representative: Emmanuèle Attout8 facts ▸
  • General meeting, 07/05/2019
  • Director resignation, Paul Howes (director)
  • Director appointment, Adrienne Graves (director)
  • Director reappointment, Philippe Vlerick (director)
  • Director reappointment, Investea BVBA (director)
  • Permanent representative, Emmanuèle Attout
  • Auditor appointment, BDO Bedrijfsrevisoren (statutory auditor)
  • Power of attorney, Claude Sander
13-06
State Gazette act Capital & shares
Statutes amendment · Power of attorney13 facts ▸
  • General meeting, 24/05/2019
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, Oxurion
  • Power of attorney, Oxurion
  • Power of attorney, Oxurion
  • Power of attorney, Oxurion
  • Power of attorney, Oxurion
  • +1 further facts in this act
17-05
State Gazette act Resignations: VIZIPHAR Biosciences BVBA, Lugo BVBA and Innov'activ BVBA
Permanent representatives: Gustaaf Van Reet, Luc Philips and 2 others · Reappointments: David Guyer (director) and ViBio BVBA (director) · Power of attorney12 facts ▸
  • General meeting, 02/05/2018
  • Director resignation, VIZIPHAR Biosciences BVBA (director)
  • Permanent representative, Gustaaf Van Reet
  • Director resignation, Lugo BVBA (director)
  • Permanent representative, Luc Philips
  • Director resignation, Innov'activ BVBA (director)
  • Permanent representative, Patricia Ceysens
  • Director reappointment, David Guyer (director)
  • Director reappointment, ViBio BVBA (director)
  • Permanent representative, Patrik De Haes
  • Power of attorney, Claude Sander
  • Number of directors, 6
2018
14-11
State Gazette act Capital & shares
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €78.737,97
  • Share issue, aandelen in gedematerialiseerde vorm, 20.375
  • Capital, €147.976.946,87
  • Bank account, KBC Bank
06-09
State Gazette act Benaming
Name change2 facts ▸
  • General meeting, 03/09/2018
  • Name change, Oxurion
03-07
State Gazette act Permanent representatives: Dominique Vanfleteren and Patrik De Haes
Power of attorney5 facts ▸
  • Board meeting, 15/03/2018
  • Power of attorney, D&V Consult BVBA
  • Permanent representative, Dominique Vanfleteren
  • Power of attorney, Vibio BVBA
  • Permanent representative, Patrik De Haes
07-06
State Gazette act Capital & shares · Miscellaneous
Reserve release · Capital decrease · Capital6 facts ▸
  • General meeting, 1 juni 2018
  • Reserve release, vermindering van de balanspost ‘uitgiftepremies’ ter aanzuivering van overgedragen verliezen
  • Capital decrease, €24.302.544,14
  • Capital, €147.898.208,9
  • Statutes amendment
  • Power of attorney, raad van bestuur en gedelegeerd bestuurder
11-04
State Gazette act Resignations: Viziphar Biosciences BVBA, Innov'Activ BVBA and Lugo BVBA
Permanent representatives: VAN REET Gustaaf, CEYSENS Patricia and PHILIPS Luc Karel9 facts ▸
  • Board meeting, 15/06/2017
  • Director resignation, Viziphar Biosciences BVBA (director)
  • Permanent representative, VAN REET Gustaaf
  • Board meeting, 31/08/2017
  • Director resignation, Innov'Activ BVBA (director)
  • Director resignation, Innov'Activ BVBA (managing director)
  • Permanent representative, CEYSENS Patricia
  • Director resignation, Lugo BVBA (director)
  • Permanent representative, PHILIPS Luc Karel
25-01
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment3 facts ▸
  • Capital increase, €9.796.303,31
  • Capital, €172.200.753,04
  • Statutes amendment
10-01
State Gazette act Appointment: BDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises (statutory auditor)
Share issue · Capital increase · Power of attorney9 facts ▸
  • General meeting, 30-10-2017
  • General meeting, 20-11-2017
  • Share issue, warrants, 1.440.000
  • Capital increase
  • Power of attorney, raad van bestuur
  • Auditor appointment, BDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises (statutory auditor)
  • Warrant price, warrant, € 4,593
  • Vvpr cancellation, geen enkel waarde meer hebben als gevolg van de afschaffing var de verminderde roerende voorheffing
  • Derogation, 520ter W.Venn., toegestaan dat warrants kunnen worden uitgeoefend vóór het einde van de periode van drie jaar, en afgeweken van bepalingen inzake spreiding in d…
2016
24-06
State Gazette act Capital & shares
Statutes amendment · Capital · Authorized capital increase5 facts ▸
  • General meeting, 06/06/2016
  • Statutes amendment
  • Capital, €162.404.449,73
  • Authorized capital increase, 162.404.449,73 EUR for 5 years
  • Share buyback mandate, max 20% of issued capital, price 90-115% of closing price, duration 3 and 5 years
08-06
State Gazette act Reappointments: Innov'activ BVBA, Thomas Clay and 2 others
Permanent representatives: Patricia Ceysens and Gustaaf Van Reet · Appointment: BDO Bedrijfsrevisoren (statutory auditor) · Mandate compensation14 facts ▸
  • General meeting, 03/05/2016
  • Director reappointment, Innov'activ BVBA (independent director)
  • Permanent representative, Patricia Ceysens
  • Mandate compensation, Innov'activ BVBA
  • Director reappointment, Thomas Clay (director)
  • Mandate compensation, Thomas Clay
  • Director reappointment, Paul Gregory Howes (director)
  • Mandate compensation, Paul Gregory Howes
  • Director reappointment, VIZIPHAR Biosciences BVBA (director)
  • Permanent representative, Gustaaf Van Reet
  • Mandate compensation, VIZIPHAR Biosciences BVBA
  • Auditor appointment, BDO Bedrijfsrevisoren (statutory auditor)
  • +2 further facts in this act
12-04
State Gazette act Appointments: Investea sprl (director) and Baron Philippe Vlerick (director)
Permanent representative: Emmanuèle Attout · Mandate compensation · Power of attorney8 facts ▸
  • General meeting, 05/05/2015
  • General meeting, 20/08/2015
  • Director appointment, Investea sprl (director)
  • Permanent representative, Emmanuèle Attout
  • Mandate compensation, Investea sprl
  • Director appointment, Baron Philippe Vlerick (director)
  • Mandate compensation, Baron Philippe Vlerick
  • Power of attorney, Claude Sander
2014
31-12
State Gazette act Capital & shares
Share issue · Capital increase · Power of attorney9 facts ▸
  • General meeting, 04/12/2014
  • Share issue, uitgifte van zevenhonderdtwintigduizend (720.000) warrants die elk recht geven op één (1) aandeel
  • Capital increase
  • Power of attorney, raad van bestuur
  • Statutes amendment
  • Warrant allocation, 60000
  • Warrant minimum price, 4.5
  • Warrant pool, pool, personeel en zelfstandige medewerkers
  • Warrant exclusion, niet-uitvoerende en onafhankelijke bestuurders
03-12
State Gazette act Resignations: LUGOST (director) and SOFIA (director)
Permanent representatives: PHILIPS Luc, BUYSSE Chris and PHILIPS Luc Karel · Appointments: LUGO (director) and HOWES Paul Gregory (director)8 facts ▸
  • General meeting, 12/11/2014
  • Director resignation, LUGOST (director)
  • Permanent representative, PHILIPS Luc
  • Director resignation, SOFIA (director)
  • Permanent representative, BUYSSE Chris
  • Director appointment, LUGO (director)
  • Permanent representative, PHILIPS Luc Karel
  • Director appointment, HOWES Paul Gregory (director)
14-10
State Gazette act Resignation: Sofia BVBA (director)
Appointment: Paul Howes (director)3 facts ▸
  • Board meeting, 28/08/2014
  • Director resignation, Sofia BVBA (director)
  • Director appointment, Paul Howes (director)
31-07
State Gazette act Resignation: Patcobel NV (director)
Permanent representatives: COLLEN Désiré José Louis, DE HAES Patrik Franciscus Albertus and BUYSE Chris Georges Frans · Appointment: GUYER David (director) · Reappointments: VIBio BVBA (director) and SOFIA BVBA (director)11 facts ▸
  • Board meeting, 05/12/2013
  • Director resignation, Patcobel NV (director)
  • Permanent representative, COLLEN Désiré José Louis
  • Board meeting, 20/12/2013
  • Director appointment, GUYER David (director)
  • General meeting, 06/05/2014
  • Director reappointment, VIBio BVBA (director)
  • Permanent representative, DE HAES Patrik Franciscus Albertus
  • Director reappointment, SOFIA BVBA (director)
  • Permanent representative, BUYSE Chris Georges Frans
  • Director appointment, GUYER David (director)
28-07
State Gazette act Resignations: Sofia BVBA (director) and Lugost BVBA (independent director)
Appointment: Lugo BVBA (director)4 facts ▸
  • Board meeting, 26/06/2014
  • Director resignation, Sofia BVBA (director)
  • Director resignation, Lugost BVBA (independent director)
  • Director appointment, Lugo BVBA (director)
2013
28-06
State Gazette act Reappointments: ViZIPHAR Biosciences BVBA (independent director) and LUGOST BVBA (independent director)
Permanent representatives: Gustaaf Van Reet and Luc Philips · Appointment: BDO Bedrijfsrevisoren (statutory auditor) · Power of attorney8 facts ▸
  • General meeting, 07/05/2013
  • Director reappointment, ViZIPHAR Biosciences BVBA (independent director)
  • Permanent representative, Gustaaf Van Reet
  • Director reappointment, LUGOST BVBA (independent director)
  • Permanent representative, Luc Philips
  • Auditor appointment, BDO Bedrijfsrevisoren (statutory auditor)
  • Power of attorney, Désiré Collen
  • Power of attorney, Chris Buyse
13-05
State Gazette act Capital & shares
Share issue · Capital increase · Capital6 facts ▸
  • Share issue, nieuwe aandelen in gedematerialiseerde vorm
  • Capital increase, €1.053.431,99
  • Capital, €162.404.449,73
  • Statutes amendment, 5
  • Warrant exercise, 118500, 107250
  • Share genot, 25/04/2013
2012
08-11
State Gazette act Appointments: ViBio BVBA, Innov'activ BVBA and Thomas Clay
Permanent representatives: Patrik De Haes and Patricia Ceysens · Reappointment: Jean-Luc Dehaene (independent director) · Power of attorney13 facts ▸
  • Board meeting, 05/03/2012
  • Director appointment, ViBio BVBA (managing director)
  • Permanent representative, Patrik De Haes
  • Power of attorney, Inge Stiers
  • Power of attorney, Allen & Overy LLP
  • General meeting, 02/05/2012
  • Director reappointment, Jean-Luc Dehaene (independent director)
  • Director appointment, Innov'activ BVBA (independent director)
  • Permanent representative, Patricia Ceysens
  • Director appointment, Thomas Clay (director)
  • Power of attorney, Désiré Collen
  • Power of attorney, Chris Buyse
  • +1 further facts in this act
31-10
State Gazette act Capital & shares
Share issue · Capital increase · Capital5 facts ▸
  • Board meeting, 17/10/2012
  • Share issue, aandelen in gedematerialiseerde vorm, 46875
  • Capital increase, €210.911,37
  • Capital, €161.351.017,74
  • Statutes amendment, Artikel 5
06-06
State Gazette act Capital & shares
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €548.558,54
  • Share issue, aandelen in gedematerialiseerde vorm, 121.917
  • Capital, €161.140.106,37
  • Statutes amendment, 5
06-06
State Gazette act Statutes amendment
2 facts ▸
  • General meeting, 21/05/2012
  • Statutes amendment
20-04
State Gazette act Capital & shares
Capital increase · Capital · Bank account5 facts ▸
  • Board meeting, 27/03/2012
  • Board meeting, 03/04/2012
  • Capital increase, €14.599.228,76
  • Capital, €160.591.547,83
  • Bank account, gestorte kapitaal en de uitgiftepremie
06-04
State Gazette act Appointment: Thomas Clay (director)
Director discharge · Power of attorney4 facts ▸
  • Board meeting, 24/08/2011
  • Director appointment, Thomas Clay (director)
  • Director discharge, Thomas Clay
  • Power of attorney, Inge Stiers
2011
23-11
State Gazette act Capital & shares
Capital increase · Share issue · Capital5 facts ▸
  • Board meeting, 28/10/2011
  • Capital increase, €148.481,61
  • Share issue, aandelen, 33000
  • Capital, €145.992.319,07
  • Bank account, KBC Bank
10-06
State Gazette act Capital & shares · Statutes amendment
Share issue · Capital increase · Power of attorney5 facts ▸
  • General meeting, 24/05/2011
  • Share issue, vijfhonderdzestienduizend (516.000) warrants die elk recht geven op één aandeel
  • Capital increase
  • Power of attorney, Raad van bestuur
  • Preemption waiver, opgeheven ten voordele van de in de desbetreffende verslagen genoemde personen
11-04
State Gazette act Capital & shares
Capital increase · Share issue · Capital4 facts ▸
  • Capital increase, €107.986,63
  • Share issue, gedematerialiseerde vorm, 24000
  • Capital, €145.843.837,46
  • Statutes amendment
2010
24-12
State Gazette act Capital & shares
Capital increase · Capital · Bank account5 facts ▸
  • Board meeting, 02/12/2010
  • Board meeting, 08/12/2010
  • Capital increase, €13.248.712,08
  • Capital, €145.735.850,83
  • Bank account, KBC Bank
07-12
State Gazette act Reappointments: PATSOVEL NV, ViBio BVBA and 5 others
Permanent representatives: COLLEN Désiré José Louis, DE HAES Patrik Franciscus Albertus and 3 others · Appointment: BDO Bedrijfsrevisoren (statutory auditor) · Mandate compensation18 facts ▸
  • General meeting, 04/05/2010
  • Director reappointment, PATSOVEL NV (director)
  • Permanent representative, COLLEN Désiré José Louis
  • Director reappointment, ViBio BVBA (director)
  • Permanent representative, DE HAES Patrik Franciscus Albertus
  • Director reappointment, SOFIA BVBA (director)
  • Permanent representative, BUYSE Chris Georges Frans
  • Director reappointment, Landon Thomas Clay (director)
  • Mandate compensation, PATSOVEL NV
  • Mandate compensation, ViBio BVBA
  • Mandate compensation, SOFIA BVBA
  • Mandate compensation, Landon Thomas Clay
  • +6 further facts in this act
08-11
State Gazette act Capital & shares
Capital increase · Share issue · Capital5 facts ▸
  • Board meeting, 22/10/2010
  • Capital increase, €1.300.338,9
  • Share issue, 22/10/2010
  • Capital, €132.487.138,75
  • Statutes amendment
15-06
State Gazette act Capital & shares · Resignations & appointments
Statutes amendment · Share issue · Auditor report5 facts ▸
  • General meeting, 27/05/2010
  • Statutes amendment
  • Statutes amendment
  • Share issue, Issuance of 600,000 warrants, each giving right to 1 share, under Warrantenplan 2010. Pre-emptive rights waived in favor of personnel and specific management se…
  • Auditor report, 16/04/2010
07-04
State Gazette act Capital & shares
Capital increase · Share issue · Capital5 facts ▸
  • Board meeting, 22/03/2010
  • Capital increase, €434.947,62
  • Share issue, 22/03/2010
  • Capital, €131.186.799,85
  • Statutes amendment, Artikel 5
2008
12-06
State Gazette act Statutes amendment · Resignations & appointments
Warrant issue · Approval10 facts ▸
  • General meeting, 26/05/2008
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Warrant issue, warrants, 450.000
  • Approval, Goedkeuring 'change of control' clausule in warrantovereenkomsten (bestaande en toekomstige)
2007
01-06
State Gazette act Restructuring
Merger1 fact ▸
  • Merger, 18/05/2007
29-05
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment5 facts ▸
  • Board meeting, 07/05/2007
  • Capital increase, €9.964.329,2
  • Capital, €109.607.643,7
  • Statutes amendment
  • Conversion, omzetting in aandelen
2006
03-07
State Gazette act Resignation: COLLEN Désiré José Louis (director)
Appointment: PATCOBEL (director) · Permanent representative: COLLEN Désiré · Share issue7 facts ▸
  • Share issue, 500000, 500 000 warrants die ... elk recht geven op één aandeel
  • Capital increase
  • Power of attorney, ThromboGenics
  • Statutes amendment, Artikel 1
  • Director resignation, COLLEN Désiré José Louis (director)
  • Director appointment, PATCOBEL (director)
  • Permanent representative, COLLEN Désiré (permanent representative)
14-06
State Gazette act Incorporation
Appointments: COLLEN Désiré José Louis, GUISE Andrew David and 2 others · Founder · Founding capital9 facts ▸
  • Incorporation, 30/05/2006
  • Founder, BIGGAR LIMITED
  • Founding capital, euro 62.000
  • Bank account, KBC Bank
  • Director appointment, COLLEN Désiré José Louis (director)
  • Director appointment, GUISE Andrew David (director)
  • Director appointment, CLAY Landon Thomas (director)
  • Auditor appointment, KLYNVELD PEAT MARWICK GOERDELER - BEDRIJFSREVISOREN (statutory auditor)
  • Power of attorney, STASSEN Jean Mane Eugène Isidoor
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
109 of 111 acts read
About the unread acts

Of the 111 Belgian State Gazette acts we know for this company, 109 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 directors, 2 in day-to-day management, last change in 2025

Board 5

Charles Paris de Bollardière
Chair · since 28-12-2023 · Onafhankelijke niet uitvoerende bestuurder · since 28-12-2023
Current
MeRoNo
Non-executive director and chair · since 15-05-2021 · Private limited company · perm. rep.: Patrik De Haes
Current
Tom Graney
Director · since 13-08-2021
Current
James Hartmann
Onafhankelijke niet uitvoerende bestuurder · since 28-12-2023
Current
Nelly Souleymane
Onafhankelijke niet uitvoerende bestuurder · since 14-02-2025
Current
8 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
CLAY Landon Thomas
Director · since 30-05-2006
Not recently confirmed
GUISE Andrew David
Director · since 30-05-2006
Not recently confirmed
Jean Luc Marie Dehaene
Independent director · since 04-05-2010
Not recently confirmed
Vibio
Director · since 04-05-2010 · Private limited company · perm. rep.: Patrik De Haes
Not recently confirmed
Jean-Luc Dehaene
Independent director · since 02-05-2012
Not recently confirmed
LUGO
Director · since 30-06-2014 · Legal entity · perm. rep.: PHILIPS Luc Karel
Not recently confirmed
Investea sprl
Director · since 05-05-2015 · Legal entity · perm. rep.: Emmanuèle Attout
Not recently confirmed
INVESTEA
Director · since 07-05-2019 · Private limited company · perm. rep.: Emmanuèle Attout
Not recently confirmed

Day-to-day management 2

Tom Graney
Ceo · since 15-05-2021
Current
MARS SARL
Managing director · since 28-12-2023 · Legal entity · perm. rep.: Pascal Ghoson
Current
1 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
ViBio BVBA
Managing director · since 05-03-2012 · Legal entity · perm. rep.: Patrik De Haes
Not recently confirmed

Permanent representatives 2

Patrik De Haes
Permanent representative · since 15-05-2021 · for MeRoNo
Current
Pascal Ghoson
Permanent representative · since 28-12-2023 · for MARS SARL
Current
2 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
PHILIPS Luc Karel
Permanent representative · since 30-06-2014 · for LUGO
Not recently confirmed
Emmanuèle Attout
Permanent representative · since 07-05-2019 · for INVESTEA
Not recently confirmed

Statutory auditor 1

BV PwC Bedrijfsrevisoren
Statutory auditor · since 15-06-2022 · perm. rep.: Didier Delanoye
Current

Other functions 2

Andy Deene
Cdo · since 28-12-2023
Current
Philippe Barbeaux
Cso · since 28-12-2023
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
2 of this company's 111 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2006
seat establishment approximate The establishment unit on the map
Ground area
4.4 ha
Building footprint
1,187 m²
Volume, LiDAR
15,276 m³
2 parcels, Brussels, Flanders · tallest building 17.0 m, ±4 floors. Linked by address, not a title deed.
26 companies at this address See who is registered here
1 establishment unit
Werkhuizenkaai 160, 1000 Brussel
Activities of head offices
since 20062.232.967.615
2 parcels
Flanders 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
21813F0611/00L000 Brussels 3.7 ha 1 · 48 m² 11.0 m · 1 fl.
24040B0201/00H002 Flanders 7,000 m² 1 · 1,139 m² 17.0 m · 4 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

43 people since 2006, 18 in office
Show
  • Board
  • Day-to-day management
  • Statutory auditor
  • Other function
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
MeRoNo
  • (niet uitvoerend) bestuurder, from 15-05-2021 to date
Tom Graney
  • Ceo, from 15-05-2021 to date
  • Director, from 13-08-2021 to date
Charles Paris de Bollardière
  • Chair, from 28-12-2023 to date
  • Onafhankelijke niet uitvoerende bestuurder, from 28-12-2023 to date
James Hartmann
  • Onafhankelijke niet uitvoerende bestuurder, from 28-12-2023 to date
Nelly Souleymane
  • Onafhankelijke niet uitvoerende bestuurder, from 14-02-2025 to date
MARS SARL
  • Managing director, from 28-12-2023 to date
BV PwC Bedrijfsrevisoren
  • Statutory auditor, from 15-06-2022 to date
Andy Deene
  • Cdo, from 28-12-2023 to date
Philippe Barbeaux
  • Cso, from 28-12-2023 to date
CLAY Landon Thomas
  • Director, from 30-05-2006 not ended, last confirmed 07-12-2010
GUISE Andrew David
  • Director, from 30-05-2006 not ended, last confirmed 14-06-2006
Jean Luc Marie Dehaene
  • Independent director, already before 04-05-2010 not ended, last confirmed 07-12-2010
Vibio
  • Director, already before 04-05-2010 not ended, last confirmed 17-05-2019
Jean-Luc Dehaene
  • Independent director, already before 02-05-2012 not ended, last confirmed 08-11-2012
LUGO
  • Director, from 30-06-2014 not ended, last confirmed 03-12-2014
Investea sprl
  • Director, from 05-05-2015 not ended, last confirmed 12-04-2016
INVESTEA
  • Director, already before 07-05-2019 not ended, last confirmed 08-08-2019
ViBio BVBA
  • Managing director, from 05-03-2012 not ended, last confirmed 08-11-2012
Anat Loewenstein
  • Onafhankelijke, niet uitvoerende bestuurder, from 15-03-2023 to 13-01-2025
  • Onafhankelijke, niet uitvoerende bestuurder, from 15-03-2023 ended, last mentioned 26-09-2023
Nathalie Laarakker
  • Onafhankelijke, niet uitvoerende bestuurder, from 15-03-2023 to 13-01-2025
  • Onafhankelijke, niet uitvoerende bestuurder, from 15-03-2023 ended, last mentioned 26-09-2023
Kathleen Paisley
  • Clo, until 28-12-2023
MeRoNo BV
  • Chair, from 15-05-2021 ended, last mentioned 25-10-2021
  • Non-executive director, from 15-05-2021 to 28-12-2023
Michaël Dillen
  • Cbo, until 28-12-2023
Thomas Clay
  • Director, from 24-08-2011 to 28-12-2023
Thomas Graney
  • Executive director, already before 03-05-2022 to 28-12-2023
  • Uitvoerend bestuurder en ceo, from 02-05-2023 to 28-12-2023
Investea SRL
  • Director, until 02-05-2023
Philippe Vlerick
  • Director, from 20-08-2015 to 02-05-2023
Adrienne Graves
  • Director, from 07-05-2019 to 13-03-2023
Dr. David Guyer
  • Director, from 20-12-2013 to 10-03-2023
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
  • Statutory auditor, from 07-12-2010 to 15-06-2022
ViBio BV
  • Director, until 15-05-2021
  • Executive director, until 15-05-2021
HOWES Paul Gregory
  • Director, from 28-08-2014 to 26-10-2018
Innov'activ BVBA
  • Independent director, from 02-05-2012 to 07-09-2017
Lugo BVBA
  • Director, from 30-06-2014 to 07-09-2017
VIZIPHAR Biosciences
  • Independent director, already before 04-05-2010 to 15-06-2017
VIZIPHAR Biosciences BVBA
  • Independent director, already before 28-06-2013 to 15-06-2017
Sofia BVBA
  • Director, until 30-06-2014
  • Director, until 14-10-2014
LUGOST
  • Independent director, already before 04-05-2010 to 30-06-2014
Lugost BVBA
  • Independent director, already before 28-06-2013 to 30-06-2014
SOFIA
  • Director, already before 04-05-2010 to 30-06-2014
PATCOBEL
  • Director, from 07-06-2006 to 05-12-2013
Klynveld Peat Marwick Goerdeler - Bedrijfsrevisoren
  • Statutory auditor, from 14-06-2006 to 07-12-2010
COLLEN Désiré José Louis
  • Director, from 30-05-2006 to 07-06-2006
See the board, name and seat on a given date →

Articles of association

Purpose
De vennootschap heeft tot doel: (i) alle verrichtingen die betrekking hebben op de ontwikkeling, de fabricatie, de exploitatie, de import, de export, de koop, de verkoop, de…
Full purpose

De vennootschap heeft tot doel: (i) alle verrichtingen die betrekking hebben op de ontwikkeling, de fabricatie, de exploitatie, de import, de export, de koop, de verkoop, de distrbutie, de promotie en/of de verhandeling in de ruimste zin van het woord van alle soorten gepatenteerde, farmaceutische, parafarmaceutische, therapeutische, lichaamsverzorgende, medische, paramedische en geneeskrachtige bereidingen, scheikundige mengsels, producten en artikelen, :industriële bereidingen van al dan niet gedeponeerde handelsmerken, patentgeneesmiddelen en drogistenjartıkelen, deze opsomming exemplatief en niet limitatief zijnde; (ii) alle vernchtingen die verband houden met de activiteiten van een scherkundıge analist en consulent; (ii) alle werkzaamheden op het gebied van studie, research en analyse die verband houden met alle hoger vermelde activiteiten, met inbegrip van de organisatie van studiedagen, seminaries en congressen die verband houden met de hoger vermelde activiteiten. De vennootschap mag, zowel in België als in het buitenland, alle industriéle, commercièle en financièle verrichtingen uitvoeren die rechtstreeks of onrechtstreeks de activiteiten van de vennootschap doen ontwikkelen of bevorderen. De vennootschap mag alle onroerende en andere goederen verwerven, ongeacht of die rechtstreeks of onrechtstreeks verband houden met haar maatschappelijk doel. De vennootschap mag leningen toestaan en waarborgen of zekerheden verstrekken aan alle verbonden ondernemingen, inclusief hypotheken. De vennootschap mag deelnemen, samenwerken of samensmelten met elke vereniging, bedrijvigheid, vennootschap of onderneming met een identiek, gelijkaardig of verwant doel, of die van aard is het doel van de vennootschap te begunstigen of de afzet van haar producten of diensten te vergemakkelıjken. De vennootschap kan optreden als bestuurder, zaakvoerder, dırecteur of vereffenaar van andere vennootschappen. De vennootschap zal zich dienen te onthouden van werkzaamheden die vergunningsplichtig zijn, zonder: voorafgaand de nodige vergunningen te hebben bekomen.

Capital
Power of attorney
One provision in the deed

Structure & network

Owners and holdings

3 holdings

Owners 0

The accounts to 31-12-2024 list no shareholders, and no other source names one.

Holdings 3

According to the 2024 annual accounts of Oxurion and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

18 connected companies
Linked via shared directors
BESIX Group
Shared director
→
ETEX
Shared director
→
EXMAR
Shared director
→
Fondation Francqui
Shared director
→
Show 14 more companies with a shared director
Fund+
Shared director
→
IVC
Shared director
→
KBC ASSURANCES
Shared director
→
KBC Bank
Shared director
→
KBC Global Services
Shared director
→
KBC Groupe
Shared director
→
MEDIAHUIS
Shared director
→
Mediahuis Partners
Shared director
→
PENTAHOLD
Shared director
→
Smartphoto group
Shared director
→
→
VLERICK RESEARCH
Shared director
→
ATENOR
Shared corporate director
→

Acquisitions and mergers

1 transaction
Took over:Thromb-X NV
proposal · State Gazette act of 01-06-2007 · effective 18-05-2007

Capital and shareholders

Shareholders according to the acts
After the capital increase act of 30-06-2026 ↗
  • Nieuwe Investeerder
After the capital increase act of 17-02-2026 ↗
  • Nieuwe Investeerder
After the capital increase act of 18-04-2025 ↗
  • Nieuwe Investeerder
After 6 capital increases act of 23-02-2023 ↗
  • Negma Group Investment Ltd
At incorporation act of 14-06-2006 ↗
  • BIGGAR LIMITED sole founder · 100% at incorporation

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 27-08-2026 Capital increase of 75,000 EUR · to 87,206,161.32 EUR · conversion
  2. 30-06-2026 Capital increase of 75,000 EUR · to 87,131,161.32 EUR · 22,358,269 new shares
  3. 30-03-2026 Capital increase of 100,000 EUR · to 87,056,161.32 EUR
  4. 17-02-2026 Capital increase of 50,000 EUR · to 86,956,161.32 EUR · 7,500,360 new shares
  5. 04-11-2025 Capital increase of 100,000 EUR · to 86,806,161.32 EUR · 5,990,086 new shares
  6. 04-11-2025 Capital increase of 100,000 EUR · to 86,906,161.32 EUR · 6,230,425 new shares
  7. 08-08-2025 Capital increase of 125,000 EUR · to 85,981,161.32 EUR · 5,580,809 new shares
  8. 08-08-2025 Capital increase of 175,000 EUR · to 86,156,161.32 EUR · 7,813,133 new shares
Show 101 older capital entries
  1. 08-08-2025 Capital increase of 250,000 EUR · to 86,406,161.32 EUR · 11,161,618 new shares
  2. 08-08-2025 Capital increase of 300,000 EUR · to 86,706,161.32 EUR · 13,393,942 new shares
  3. 10-07-2025 Capital increase of 100,000 EUR · to 85,856,161.32 EUR
  4. 11-06-2025 Capital increase of 100,000 EUR · to 85,656,161.32 EUR · 1,521,372 new shares
  5. 11-06-2025 Capital increase of 100,000 EUR · to 85,756,161.32 EUR · 2,340,268 new shares
  6. 18-04-2025 Capital increase of 150,000 EUR · to 85,556,161.32 EUR · 996,319 new shares
  7. 30-01-2025 Capital increase of 150,000 EUR · to 85,306,161.32 EUR · 624,817 new shares
  8. 30-01-2025 Capital increase of 100,000 EUR · to 85,406,161.32 EUR · 446,121 new shares
  9. 19-12-2024 Capital increase of 150,000 EUR · to 85,156,161.32 EUR · 564,856 new shares
  10. 13-11-2024 Capital increase of 150,000 EUR · to 85,006,161.32 EUR · 452,841 new shares
  11. 27-09-2024 Capital increase of 100,000 EUR · to 84,856,161.32 EUR
  12. 23-08-2024 Capital increase of 100,000 EUR · to 84,756,161.32 EUR
  13. 05-06-2024 Capital increase of 100,000 EUR · to 84,456,161.32 EUR
  14. 05-06-2024 Capital increase of 200,000 EUR · to 84,656,161.32 EUR
  15. 23-04-2024 Capital increase of 150,000 EUR · to 84,206,161.32 EUR
  16. 23-04-2024 Capital increase of 150,000 EUR · to 84,356,161.32 EUR
  17. 25-03-2024 Capital increase of 150,000 EUR · to 83,906,161.32 EUR
  18. 25-03-2024 Capital increase of 150,000 EUR · to 84,056,161.32 EUR
  19. 14-02-2024 Capital increase of 150,000 EUR · to 83,556,161.32 EUR
  20. 14-02-2024 Capital increase of 100,000 EUR · to 83,656,161.32 EUR
  21. 14-02-2024 Capital increase of 100,000 EUR · to 83,756,161.32 EUR
  22. 04-12-2023 Capital increase of 50,000 EUR · to 83,006,161.32 EUR
  23. 04-12-2023 Capital increase of 100,000 EUR · to 83,106,161.32 EUR
  24. 04-12-2023 Capital increase of 100,000 EUR · to 83,206,161.32 EUR
  25. 04-12-2023 Capital increase of 200,000 EUR · to 83,406,161.32 EUR
  26. 06-11-2023 Capital increase of 100,000 EUR · to 82,856,161.32 EUR · 90,579,710 new shares
  27. 06-11-2023 Capital increase of 100,000 EUR · to 82,956,161.32 EUR · 120,772,946 new shares
  28. 26-09-2023 Capital increase of 200,000 EUR · to 82,206,161.32 EUR
  29. 26-09-2023 Capital increase of 250,000 EUR · to 82,456,161.32 EUR
  30. 26-09-2023 Capital increase of 150,000 EUR · to 82,606,161.32 EUR
  31. 26-09-2023 Capital increase of 150,000 EUR · to 82,756,161.32 EUR
  32. 28-08-2023 Capital increase of 150,000 EUR · to 81,006,161.32 EUR · 97,826,086 new shares
  33. 28-08-2023 Capital increase of 300,000 EUR · to 81,306,161.32 EUR · 191,815,856 new shares
  34. 28-08-2023 Capital increase of 200,000 EUR · to 81,506,161.32 EUR · 127,877,237 new shares
  35. 28-08-2023 Capital increase of 150,000 EUR · to 81,656,161.32 EUR · 94,063,545 new shares
  36. 28-08-2023 Capital increase of 150,000 EUR · to 81,806,161.32 EUR · 92,288,761 new shares
  37. 28-08-2023 Capital increase of 200,000 EUR · to 82,006,161.32 EUR · 123,051,681 new shares
  38. 19-07-2023 Capital increase of 150,000 EUR · to 80,706,161.32 EUR
  39. 19-07-2023 Capital increase of 150,000 EUR · to 80,856,161.32 EUR
  40. 25-05-2023 Capital increase of 200,000 EUR · to 79,156,161.32 EUR · 44,669,446 new shares
  41. 25-05-2023 Capital increase of 100,000 EUR · to 79,256,161.32 EUR · 23,801,967 new shares
  42. 09-05-2023 Capital increase of 150,000 EUR · to 78,606,161.32 EUR
  43. 09-05-2023 Capital increase of 250,000 EUR · to 78,856,161.32 EUR
  44. 09-05-2023 Capital increase of 100,000 EUR · to 78,956,161.32 EUR
  45. 21-04-2023 Capital increase of 200,000 EUR · to 77,906,161.32 EUR
  46. 21-04-2023 Capital increase of 300,000 EUR · to 78,206,161.32 EUR
  47. 21-04-2023 Capital increase of 250,000 EUR · to 78,456,161.32 EUR
  48. 23-02-2023 Capital increase of 500,000 EUR · to 76,356,161.32 EUR
  49. 23-02-2023 Capital increase of 150,000 EUR · to 76,506,161.32 EUR
  50. 23-02-2023 Capital increase of 200,000 EUR · to 76,706,161.32 EUR
  51. 23-02-2023 Capital increase of 400,000 EUR · to 77,106,161.32 EUR
  52. 23-02-2023 Capital increase of 400,000 EUR · to 77,506,161.32 EUR
  53. 23-02-2023 Capital increase of 200,000 EUR · to 77,706,161.32 EUR
  54. 16-12-2022 Capital increase of 140,000 EUR · to 73,121,161.32 EUR
  55. 16-12-2022 Capital increase of 430,000 EUR · to 73,551,161.32 EUR
  56. 16-12-2022 Capital increase of 350,000 EUR · to 73,901,161.32 EUR
  57. 16-12-2022 Capital increase of 605,000 EUR · to 74,506,161.32 EUR
  58. 16-12-2022 Capital increase of 200,000 EUR · to 74,706,161.32 EUR
  59. 16-12-2022 Capital increase of 200,000 EUR · to 74,906,161.32 EUR
  60. 16-12-2022 Capital increase of 950,000 EUR · to 75,856,161.32 EUR
  61. 21-11-2022 Capital increase of 265,000 EUR · to 71,603,661.32 EUR · 3,785,714 new shares
  62. 21-11-2022 Capital increase of 145,000 EUR · to 71,748,661.32 EUR · 2,071,428 new shares
  63. 21-11-2022 Capital increase of 300,000 EUR · to 72,048,661.32 EUR · 5,000,000 new shares
  64. 21-11-2022 Capital increase of 307,500 EUR · to 72,356,161.32 EUR · 6,150,000 new shares
  65. 21-11-2022 Capital increase of 300,000 EUR · to 72,656,161.32 EUR · 15,000,000 new shares
  66. 21-11-2022 Capital increase of 325,000 EUR · to 72,981,161.32 EUR · 16,250,000 new shares
  67. 21-10-2022 Capital increase of 100,000 EUR · to 71,006,161.32 EUR · 909,090 new shares
  68. 21-10-2022 Capital increase of 332,500 EUR · to 71,338,661.32 EUR · 4,750,000 new shares
  69. 21-09-2022 Capital increase of 200,000 EUR · to 70,906,161.32 EUR
  70. 12-09-2022 Capital increase of 200,000 EUR · to 70,706,161.32 EUR
  71. 22-08-2022 Capital increase of 500,000 EUR · to 70,506,161.32 EUR · 1,785,714 new shares
  72. 15-07-2022 Capital increase of 550,000 EUR · to 70,006,161.32 EUR · 1,447,368 new shares
  73. 14-06-2022 Capital increase of 450,000 EUR · to 69,456,161.32 EUR · 1,216,216 new shares
  74. 23-05-2022 Capital increase of 500,000 EUR · to 69,006,161.32 EUR · 980,392 new shares
  75. 22-04-2022 Capital increase of 575,000 EUR · to 68,506,161.32 EUR · 495,689 new shares
  76. 28-03-2022 Capital increase of 600,000 EUR · to 67,931,161.32 EUR · 500,000 new shares
  77. 17-03-2022 Capital increase of 10,405,500 EUR · 7,226,039 new shares · in cash
  78. 15-02-2022 Capital increase of 483,219.36 EUR · to 56,925,661.32 EUR · 335,569 new shares
  79. 07-01-2022 Capital increase of 293,022.72 EUR · to 56,442,441.96 EUR · 203,488 new shares
  80. 02-12-2021 Capital increase of 378,946.08 EUR · to 56,149,419.24 EUR · 263,157 new shares
  81. 25-10-2021 Capital increase of 225,000 EUR · to 55,770,473.16 EUR · 156,250 new shares
  82. 21-10-2021 Capital increase of 219,512.16 EUR · to 55,545,473.16 EUR · 152,439 new shares
  83. 28-08-2020 Capital reduction of 50,198,374.38 EUR · to 60,858,557.62 EUR · aanzuivering geleden verliezen
  84. 28-08-2020 Capital reduction of 5,532,596.62 EUR · to 55,325,961 EUR · to absorb losses
  85. 14-01-2020 Capital reduction · to 111,056,932 EUR · “formele kapitaalvermindering zonder vernietiging van bestaande aandelen”
  86. 14-11-2018 Capital increase of 78,737.97 EUR
  87. 07-06-2018 Capital reduction of 24,302,544.14 EUR · to 147,898,208.90 EUR · “aanzuivering van geledene verliezen”
  88. 25-01-2018 Capital increase of 9,796,303.31 EUR · 2,177,226 new shares
  89. 24-06-2016 Capital stated in the act · 162,404,449.73 EUR
  90. 13-05-2013 Capital increase of 1,053,431.99 EUR · in cash
  91. 31-10-2012 Capital increase of 210,911.37 EUR
  92. 06-06-2012 Capital increase of 548,558.54 EUR · to 161,140,106.37 EUR
  93. 20-04-2012 Capital increase of 14,599,228.76 EUR · to 160,591,547.83 EUR · in cash
  94. 23-11-2011 Capital increase of 148,481.61 EUR · 33,000 new shares
  95. 10-06-2011 Capital increase · 516,000 new shares
  96. 11-04-2011 Capital increase of 107,986.63 EUR · 24,000 new shares · “uitoefening van warrants”
  97. 24-12-2010 Capital increase of 13,248,712.08 EUR · to 145,735,850.83 EUR
  98. 08-11-2010 Capital increase of 1,300,338.90 EUR · 289,000 new shares · “uitoefening van warrants”
  99. 07-04-2010 Capital increase of 434,947.62 EUR · 96,667 new shares · “uitoefening van warrants”
  100. 29-05-2007 Capital increase of 9,964,329.20 EUR · to 109,607,643.70 EUR · in cash
  101. 14-06-2006 Incorporation · 62,000 EUR

Public money · subsidies and aid

European research

2 projects · 35,000 EUR EU contribution
Programmes
1 entry · 35,000 EUR
Projects
Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia
Horizon 2020 · participant · 01-01-2020 to 31-12-2024 · 35,000 EUR · RECOGNISED
European Consortium for Anticancer Antibody Development
Seventh Framework Programme · participant · 01-05-2008 to 30-04-2012 · EUCAAD

Recognitions · licences · registrations

Legal Entity Identifier

549300VWY8KVDFKLDM59
live in the LEI register

Similar companies · same sector, comparable size

Of 5,712 companies in sector 70100 we hold annual accounts for 3,504. 517 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded30-05-2006
Fiscal year end31-12
Activities, NACEBEL 2025
70100Activities of head offices
64210Activities of holding companies
Contact
E-mail info@oxurion.com
Phone +3216751310
E-invoicing
Reachable via Peppol
Peppol ID 0208:0881620924
Also 9925:BE0881620924
Registered 17-12-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

General meetings

24 convocations
Ordinary general meeting
on 13-05-2025 at 14u · published 11-04-2025
Agenda
. 42716 MONITEUR BELGE — 11.04.2025 — BELGISCH STAATSBLAD AGENDA JAARVERGADERING : Agenda van de jaarvergadering met commentaar van de raad van bestuur en voorstellen tot besluit 1. Kennisname van het uitstel van de gewone algemene vergadering van aandeelhouders en verklaring van afstand. Commentaar bij dit agendapunt : De raad van bestuur verduidelijkt dat wegens organisatorische redenen was het niet mogelijk om de gewone algemene vergadering van aandeelhouders te laten plaatsvinden op de statutaire datum, zijnde de eerste dinsdag van mei (i.e. 6 mei 2025). Voorstel tot besluit : Na kennis genomen te hebben van de redenen van de raad van bestuur over het uitstel van de gewone algemene verga ...
Extraordinary general meeting
on 04-07-2024 at 11u · published 05-07-2024
Agenda
punten van de eerste buitengewone algemene vergadering van de Vennootschap gehouden op donderdag 4 juli 2024, om 11 uur (Belgische tijd, GMT+1), voor notaris Yorik Desmyttere, te Lloyd Georgelaan 11, 1000 Brussel (België), worden de houders van effecten van de Vennootschap uitgenodigd tot het bijwonen van een tweede buitengewone algemene vergadering die zal worden gehouden op woensdag 24 juli 2024, om 15 uur (Belgische tijd, GMT+1), voor notaris Peter Van Melkebeke (of een andere geassoci- eerde notaris van het kantoor Berquin notarissen CVBA), te Lloyd Georgelaan 11, 1000 Brussel (België), met de onderstaande agenda. Overeenkomstig het Wetboek van vennootschappen en verenigingen (WVV) is er ...
Extraordinary general meeting
on 04-07-2024 at 11u · published 04-06-2024
Agenda
. Overeenkomstig het Wetboek van vennootschappen en verenigingen (WVV) moet minstens een aanwezigheidsquorum van 50 % van de uitstaande aandelen aanwezig of vertegenwoordigd zijn op de buitengewone algemene vergadering voor de beraadslaging en stem- ming over de punten op de agenda. In het geval het wettelijk vereiste quorum om te beraadslagen en te besluiten niet is bereikt en een tweede oproeping is vereist, zal een tweede buitengewone algemene vergade- ring plaatsvinden op woensdag 24 juli 2024, om 15 uur (Belgische tijd, GMT+1), tenzij, indien van toepassing, hiertoe anders wordt besloten door de raad van bestuur. Deze tweede buitengewone algemene vergadering, indien van toepassing, zal ...
Ordinary general meeting
on 24-04-2024 at 17u · published 15-04-2024
Agenda
. AGENDA JAARVERGADERING : Agenda van de jaarvergadering met commentaar van de raad van bestuur en voorstellen tot besluit 1. Kennisname van het uitstel van de gewone algemene vergadering van aandeelhouders en verklaring van afstand. Commentaar bij dit agendapunt : De raad van bestuur verduidelijkt dat wegens organisatorische redenen was het niet mogelijk om de gewone algemene vergadering van aandeelhouders te laten plaatsvinden op de statutaire datum, zijnde de eerste dinsdag van mei (i.e. 7 mei 2024). Voorstel tot besluit : Na kennis genomen te hebben van de redenen van de raad van bestuur over het uitstel van de gewone algemene vergadering van aandeelhouders, verklaren de aandeelhouders z ...
General meeting
on 22-05-2023 at 14u · published 21-04-2023
Agenda
. AGENDA BIJZONDERE ALGEMENE VERGADERING Agenda van de bijzondere algemene vergadering met commentaar van de raad van bestuur en voorstellen tot besluit 1. Goedkeuring controlewijzigingsclausule in het kader van artikel 7:151 van het Wetboek van vennootschappen en verenigingen (het “WVV”). Commentaar bij het agendapunt : Ingevolge artikel 7:151 van het WVV is enkel de algemene vergadering bevoegd om zogenoemde « controlewijzigingsclausules » goed te keuren, i.e. bepalingen waarbij aan derden rechten worden toegekend die een aanzienlijke invloed hebben op het vermogen van de Vennootschap, dan wel een aanzienlijke schuld of verplichting ten laste van de Vennootschap doen ontstaan, wanneer de u ...
Show 19 more convocations
Extraordinary general meeting
on 03-05-2022 at 10u · published 04-04-2022
Agenda
. Overeenkomstig het Wetboek van vennootschappen en verenigingen (WVV) moet minstens een aanwezigheidsquorum van 50 % van de uitstaande aandelen aanwezig of vertegenwoordigd zijn op de buitengewone algemene vergadering voor de beraadslaging en stem- ming over de punten op de agenda. In het geval het wettelijk vereiste quorum om te beraadslagen en te besluiten niet is bereikt en een tweede oproeping is vereist, zal deze buitengewone algemene vergadering plaatsvinden op dinsdag 24 mei 2022, om 10 uur (Belgische tijd, GMT+1), tenzij, indien van toepassing, hiertoe anders wordt besloten door de raad van bestuur. Deze tweede buitengewone algemene vergadering, indien van toepassing, zal plaatsvind ...
Ordinary general meeting
on 03-05-2022 at 14u · at the registered office · published 04-04-2022
Agenda
. AGENDA JAARVERGADERING Agenda van de jaarvergadering met commentaar van de raad van bestuur en voorstellen tot besluit 1. Kennisname van : • het jaarverslag van de raad van bestuur over de jaarrekening met betrekking tot het boekjaar afgesloten op 31 december 2021 (met inbegrip van het corporate governance beleid van de Vennootschap); • het verslag van de commissaris over de jaarrekening met betrek- king tot het boekjaar afgesloten op 31 december 2021; en • de geconsolideerde jaarekening met betrekking tot het boekjaar afgesloten op 31 december 2021. Commentaar bij het agendapunt : De raad van bestuur vraagt de vergadering om kennis te nemen van het jaarverslag van de raad van bestuur van ...
Ordinary general meeting
on 09-11-2021 at 11u · published 07-10-2021
Agenda
. AGENDA : 1. Bevestiging van de benoeming van MeReNo BV, vast vertegen- woordigd door de heer Patrik De Haes, als bestuurder, na advies van het benoemings- en remuneratiecomité, en beslissing over de vergoe- ding voor de uitoefening van zijn mandaat als bestuurder. Voorstel tot besluit : Beslissing tot bevestiging van de benoeming van MeReNo BV, vast vertegenwoordigd door de heer Patrik De Haes, als bestuurder van de Vennootschap met ingang van de datum van coöptatie van deze bestuurder door de raad van bestuur op 15 mei 2021, tot na de afsluiting van de algemene vergadering die zal beslissen over de jaar- rekening over het boekjaar dat zal worden afgesloten op 31 december 2021. Zijn mandaa ...
General meeting
on 13-08-2021 at 11u · published 13-07-2021
Agenda
. AGENDA 1. Benoeming van de heer Tom Graney als bestuurder, op voorstel van de raad van bestuur van de Vennootschap, na advies van het benoemings- en remuneratiecomité. Commentaar bij het agendapunt : De CV van de heer Tom Graney is beschikbaar op de website van de Vennootschap (www.oxurion.be). Voorstel tot besluit : Beslissing tot benoeming van de heer Tom Graney als bestuurder van de Vennootschap met onmiddellijke ingang voor een periode die zal aflopen na de afsluiting van de vergadering die zal beslissen over de jaarrekening over het boekjaar dat zal worden afgesloten op 31 december 2021. Zijn bestuursmandaat zal niet worden bezoldigd. 2. Goedkeuring, op voorstel van de raad van bestuu ...
Ordinary general meeting
on 04-05-2021 at 14u · published 02-04-2021
Agenda
. In het licht van de COVID-19-pandemie, wordt momenteel voorzien dat bepaalde maatregelen opgelegd door de Belgische regering om het hoofd te bieden aan deze pandemie, zoals de verplichting om een afstand van 1,5 meter tussen elke persoon te garanderen, nog van kracht kunnen zijn op 4 mei 2021, datum van de gewone algemene aandeelhoudersvergadering van de Vennootschap. Deze maatregelen zijn in het belang van de gezondheid van individuele effectenhouders, alsook van de medewerkers van de Vennootschap en anderen die instaan voor de organisatie van de gewone algemene vergadering. Er kan ook niet worden uitgesloten dat de Belgische regering opnieuw bijkomende maatregelen zal opleggen. We volgen ...
Extraordinary general meeting
on 24-08-2020 at 14u · published 10-08-2020
Agenda
punten van de eerste buitengewone algemene vergadering van de Vennootschap gehouden op donderdag 6 augustus 2020, worden de houders van effecten van de Vennootschap uitgenodigd tot het bijwonen van een tweede buitengewone algemene vergadering die zal worden gehouden op maandag 24 augustus 2020, om 14 uur (Belgische tijd, GMT+1) op het kantoor van geassocieerde notarissen Celis, Celis & Liesse te 2000 Antwerpen, Kasteelplein- straat 59 met onderstaande agenda. Gelet op de nog steeds heersende COVID-19-pandemie waarvan de evolutie tijdens de komende weken en maanden zowel in België als in Europa onzeker is, is het in de huidige omstandigheden ook onzeker welke maatregelen opgelegd door de Belg ...
Extraordinary general meeting
on 06-08-2020 at 14:00u · published 06-07-2020
Agenda
. Indien het vereiste aanwezigheidsquorum niet wordt bereikt, zal een tweede buitengewone algemene vergadering worden gehouden op maandag 24 augustus 2020 om 14:00 uur (Belgische tijd, GMT+1), op dezelfde plaats en met dezelfde agenda. Gelet op de nog steeds heersende Covid-19-pandemie waarvan de evolutie tijdens de komende weken en maanden zowel in België als in Europa onzeker is, is het in de huidige omstandigheden ook onzeker welke maatregelen opgelegd door de Belgische regering ter bestrijding van de COVID-19-pandemie van kracht zullen zijn op 6 augustus 2020, de datum van de eerste geplande buitengewone algemene vergadering. De raad van bestuur moedigt de aandeelhouders daarom aan om hu ...
Extraordinary general meeting
on 13-12-2019 at 14u · published 13-11-2019
Agenda
. Indien het vereiste aanwezigheidsquorum niet wordt bereikt, zal een tweede buitengewone algemene vergadering worden gehouden op maandag 30 december 2019, om 14 uur (Belgische tijd, GMT+1), op dezelfde plaats en met dezelfde agenda. AGENDA Agenda en voorstellen tot besluit 1. Kennisname van het verslag van de raad van bestuur overeenkom- stig artikel 7 :228 van het Wetboek van vennootschappen en vereni- gingen met voorstel van de maatregelen tot herstel van het eigen vermogen van de Vennootschap en de voortzetting van de activiteiten 105578 MONITEUR BELGE — 13.11.2019 — BELGISCH STAATSBLAD van de Vennootschap zoals opgenomen in agendapunt 2 hierna door aanzuivering van de geleden verliezen ...
Extraordinary general meeting
on 24-05-2019 at 14u · published 07-05-2019
Agenda
punten van de eerste buitengewone algemene vergadering van de Vennootschap gehouden op dinsdag 7 mei 2019, worden de houders van effecten van de Vennootschap uitgenodigd tot het bijwonen van een tweede buitengewone algemene vergadering van de Vennootschap, die zal worden gehouden op vrijdag 43977 MONITEUR BELGE — 07.05.2019 — BELGISCH STAATSBLAD 24 mei 2019, om 14 uur (Belgische tijd, GMT+1), op het kantoor van geassocieerde notarissen Celis, Celis & Liesse, te Antwerpen, Kasteel- pleinstraat 59, met de onderstaande agenda. AGENDA : Agenda en voorstellen tot besluit 1. Vervroegde toepassing van de bepalingen van het nieuwe Wetboek van Vennootschappen (opt-in) en aanname van nieuwe statuten o ...
Extraordinary general meeting
on 03-09-2018 at 14u · published 17-08-2018
Agenda
punten van de eerste buitenge- wone algemene vergadering van de Vennootschap gehouden op vrijdag 27 juli 2018, worden de houders van effecten van de Vennoot- schap uitgenodigd tot het bijwonen van een tweede buitengewone algemene vergadering van de Vennootschap, die zal worden gehouden op maandag 3 september 2018, om 14 uur (Belgische tijd, GMT+1), op het kantoor van geassocieerde notarissen Celis, Celis & Liesse, te Antwerpen, Kasteelpleinstraat 59, met de onderstaande agenda. AGENDA Agenda en voorstellen tot besluit 1. Wijziging vennootschapsnaam en statutenwijziging Voorstel tot besluit : Beslissing tot wijziging van de naam van de Vennootschap van “Thrombogenics” naar “Oxurion” met ingan ...
Extraordinary general meeting
on 27-07-2018 at 14u · published 27-06-2018
Agenda
. Indien het vereiste aanwezigheidsquorum niet wordt bereikt, zal een tweede buitengewone algemene vergadering worden gehouden op het kantoor van geassocieerde notarissen Celis, Celis & Liesse te Antwerpen, Kasteelpleinstraat 59, op maandag 3 september 2018, om 14 uur (Belgische tijd, GMT+1), met dezelfde agenda. AGENDA Agenda en voorstellen tot besluit 1. Wijziging vennootschapsnaam en statutenwijziging Voorstel tot besluit : Beslissing tot wijziging van de naam van de Vennootschap van “Thrombogenics” naar “Oxurion” met ingang vanaf 10 september 2018 en wijziging van artikel 1 van de statuten van de Vennootschap overeenkomstig dit besluit. 2. Volmachten. Voorstel tot besluit : De vergaderin ...
Extraordinary general meeting
on 01-06-2018 at 14u · published 15-05-2018
Agenda
punten van de eerste buitengewone algemene vergadering van de Vennootschap gehouden op woensdag 2 mei 2018, worden de houders van effecten van de Vennootschap uitgenodigd tot het bijwonen van een tweede buitengewone algemene vergadering van de Vennootschap, die zal worden gehouden op vrijdag 1 juni 2018 om 14 uur (Belgische tijd, GMT+1), op het kantoor van geassocieerde notarissen Celis, Celis & Liesse te Antwerpen, Kasteel- pleinstraat 59, met de onderstaande agenda. AGENDA Agenda en voorstellen tot besluit 1. Vermindering uitgiftepremies ter aanzuivering van geleden verliezen Voorstel tot besluit : Beslissing tot vermindering van de balanspost ‘uitgiftepremies’ met een bedrag van honderdze ...
Extraordinary general meeting
on 20-11-2017 at 15u · published 31-10-2017
Agenda
punten van de eerste buitengewone algemene vergadering van de Vennootschap gehouden op maandag 30 oktober 2017, worden de houders van effecten van de Vennootschap uitgenodigd tot het bijwonen van een tweede buitengewone algemene vergadering van de Vennootschap, die zal worden gehouden op maandag 20 november 2017, om 15 uur (Belgische tijd, GMT+1), op het kantoor van geassocieerde notarissen Celis, Celis & Liesse te Antwerpen, Kasteelpleinstraat 59, met de onderstaande agenda. AGENDA Agenda en voorstellen tot besluit Warrantenplan 2017 1. Lezing en bespreking van : • het verslag van de raad van bestuur opgesteld overeenkomstig artikel 583 W.Venn. waarin een omstandige verantwoording wordt geg ...
Extraordinary general meeting
on 30-10-2017 at 15u · published 29-09-2017
Agenda
. Indien het vereiste aanwezigheidsquorum niet wordt bereikt voor alle agendapunten van deze buitengewone algemene vergadering, dan zal er enkel worden beslist over het laatste agendapunt betreffende de opheffing van de VVPR strips waarvoor geen quorum vereist is. Wat betreft de overige agendapunten zal een tweede buitengewone alge- mene vergadering worden gehouden op het kantoor van geassocieerde notarissen Celis, Celis & Liesse te Antwerpen, Kasteelpleinstraat 59, op maandag 20 november 2017 om 15.00 uur (Belgische tijd, GMT+1), die zal beslissen over alle overige agendapunten gelet op hun samenhang. AGENDA Agenda en voorstellen tot besluit Warrantenplan 2017 1. Lezing en bespreking van : ...
Ordinary general meeting
on 02-05-2017 at 14u · published 31-03-2017
Agenda
. AGENDA Agenda van de jaarvergadering met commentaar van de raad van bestuur en voorstellen tot besluit 1. Kennisname van en beraadslaging over : het jaarverslag van de raad van bestuur van de Vennootschap over de jaarrekening afgesloten op 31 december 2016 (met inbegrip van een beraadslaging over het corporate governance beleid van de Vennoot- schap); en het verslag van de commissaris over de jaarrekening afgesloten op 31 december 2016. Commentaar bij het agendapunt : De raad van bestuur vraagt de vergadering om kennis te nemen van het jaarverslag van de raad van bestuur van de Vennootschap over de jaarrekening afgesloten op 31 december 2016 en van het verslag van de commissaris over de ja ...
Extraordinary general meeting
on 23-05-2016 at 24:00u · published 20-05-2016
Agenda
van die vergadering, worden de houders van effecten opgeroepen tot het bijwonen van een nieuwe buitengewone algemene vergadering die zal worden gehouden op het kantoor van de geassocieerde notarissen Celis, Celis & Liesse te Antwerpen, Kasteelpleinstraat 59, op maandag 6 juni 2016 om 14 :00 uur (Belgische tijd, GMT+1), met de volgende agenda. AGENDA 1. Nieuwe machtigingen aan de raad van bestuur inzake toegestaan kapitaal. (a) Kennisname van en bespreking van het bijzonder verslag van de raad van bestuur opgesteld overeenkomstig artikel 604 Wetboek van vennootschappen aangaande de machtiging bedoeld onder littera (b) hierna; (b) Toekenning van een nieuwe machtiging aan de raad van bestuur, o ...
Ordinary general meeting
on 20-08-2015 at 14u · published 17-07-2015
Agenda
heeft. AGENDA Agenda van de vergadering, commentaar van de raad van bestuur en voorstellen tot besluit 1. Benoeming van de Baron Philippe Vlerick als bestuurder, op voorstel van de raad van bestuur van de Vennootschap, na advies van het benoemings- en remuneratiecomité, en beslissing over de vergoe- ding voor de uitoefening van zijn mandaat als bestuurder. Voorstel tot besluit : Benoeming van de Baron Philippe Vlerick, tot bestuurder van de Vennootschap met onmiddellijke ingang voor een periode van vier jaar die zal aflopen na de afsluiting van de jaarvergadering die zal beslissen over de jaarrekening over het boekjaar dat zal worden afgesloten op 31 december 2018. De voornoemde bestuurder z ...
Extraordinary general meeting
on 04-12-2014 at 10u · published 17-11-2014
Agenda
van de eerste buitengewone algemene vergadering van de Vennootschap gehouden op woensdag 12 november 2014, worden de houders van effecten van de Vennootschap uitgenodigd tot het bijwonen van een tweede buitengewone algemene vergadering van de Vennootschap, die zal worden gehouden op donderdag 4 december 2014, om 10 uur (Belgische tijd, GMT+1), op het kantoor van geassocieerde notarissen Celis, Celis & Liesse te Antwerpen, Kasteelpleinstraat 59, met de onderstaande agenda. AGENDA Agenda en voorstellen tot besluit 1. Lezing en bespreking van : het verslag van de raad van bestuur opgesteld overeenkomstig artikel 583 W.Venn. waarin een omstandige verantwoording wordt gegeven van de uitgifte van ...
Ordinary general meeting
on 07-05-2013 at 14u · published 05-04-2013
Agenda
, houdende voorstellen tot besluit. Agenda van de jaarvergadering 1. Bespreking van het jaarverslag van de raad van bestuur over de jaarrekening afgesloten op 31 december 2012 (inclusief bespreking inzake corporate governance beleid) en bespreking van het verslag van de commissaris over de jaarrekening afgesloten op 31 december 2012. Commentaar bij het agendapunt : De raad van bestuur vraagt de algemene vergadering kennis te nemen van het jaarverslag van de raad van bestuur over de jaar- rekening afgesloten op 31 december 2012 en van het verslag van de commissaris over de jaarrekening afgesloten op 31 december 2012. 2. Goedkeuring van het remuneratieverslag van de raad van bestuur, zoals toe ...